MEDIS Medical Imaging Systems
_____________________________________________________________________
QCA-CMS® References
1.
Zwet PMJ van der, Pinto IMF, Serruys PW, Reiber JHC.
A new approach for the automated definition of path lines in digitized coronary
angiograms.
Int J Cardiac Imaging 1990; 5: 75-83.
2.
Reiber JHC.
An overview of coronary quantitation techniques as of 1989.
In: Quantitative Coronary Arteriography. JHC Reiber, PW Serruys, editors.
Kluwer Academic Publishers, Dordrecht 1991: 55-132.
3.
Kirkeeide RL.
Coronary obstructions, morphology and physiologic significance.
In: Quantitative Coronary Arteriography. JHC Reiber, PW Serruys, editors.
Kluwer Academic Publishers, Dordrecht 1991: 229-44.
4.
Reiber JHC, Serruys PW.
Quantitative Coronary Angiography.
In: Cardiac Imaging. ML Marcus, DJ Skorton, HR Schelbert, GL Wolf, editors.
Saunders Company, Philadelphia 1991: 211-81.
5.
Land CD von, Rao SR, Reiber JHC.
Development of an improved centreline wall motion model.
Comp Cardiol 1991: 687-90.
6.
Koning G, Zwet PMJ van der, Land CD von, Reiber JHC.
Angiographic assessment of dimensions of 6F and 7F Mallinckrodt Softouch®
coronary contrast catheters from digital and cine arteriograms.
Int J Cardiac Imaging 1992; 8: 153-61.
7.
Lespérance J, Waters D.
Measuring progression and regression of coronary atherosclerosis in clinical trials:
problems and progress.
Int J Cardiac Imaging 1992; 8: 165-73.
8.
Reiber JHC, Zwet PMJ van der, Koning G, Land CD von, Dumay ACM.
Quantitative coronary arteriography; current and future perspectives.
Cardiology Today and Tomorrow. Acts of the 4th International Cardiology
Conference. Milan, Italy, May 28-30, 1992: 8-15.
9.
Zwet PMJ van der, Reiber JHC.
A new algorithm to detect irregular coronary boundaries: the Gradient Field
Transform.
Comp Cardiol 1992: 107-10.
10. Reiber JHC, Zwet PMJ van der, Koning G, Land CD von, Gerbrands JJ,
Schalij M, Benthem AC van, Buis B.
Perspectives of routine quantitative coronary arteriography.
Neth J Cardiol 1993; 6: 132-8.
_____________________________________________________________________
QCA-CMS-References
1
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
11. Zijlstra F, Boer MJ de, Hoorntje JCA, Reiffers S, Reiber JHC, Suryapranata
H.
Vergelijking tussen directe coronaire angioplastiek en intraveneuze streptokinase bij
het acute myocardinfarct.
Neth J Cardiol 1993; 3: 185-90.
12. Waters D, Higginson L, Gladstone P, Kimball B, Le May M, Lespérance J.
Design features of a controlled clinical trial to assess the effect of an HMG CoA
reductase inhibitor on the progression of coronary artery disease.
Controlled Clinical Trials 1993; 14: 45-74.
13. Foley JB, Penn IM, Brown RIG, Murray-Parsons N, White J, Galligan L,
MacDonald C.
Safety, success, and restenosis after elective coronary implantation of the PalmazSchatz stent in 100 patients at a single center.
Am Heart J 1992; 125: 686-94.
14. Zijlstra F, Boer MJ de, Hoorntje JCA, Reiffers S, Reiber JHC, Suryapranata
H.
A comparison of immediate coronary angioplasty with intravenous streptokinase in
acute myocardial infarction.
N Eng J Med 1993; 328: 680-4.
15. Adelman AG, Cohen EA, Kimball BP, Bonan R, Ricci DR, Webb JG,
Laramee L, Barbeau G, Traboulsi M, Corbett BN, Schwartz L, Logan AG.
A comparison of directional atherectomy with balloon angioplasty for lesions of
the left anterior descending coronary artery.
N Eng J Med 1993; 329: 228-33.
16. Reiber JHC, Zwet PMJ van der, Land CD von, Koning G, Meurs B van, Buis
B, Voorthuisen AE van.
Quantitative coronary arteriography: equipment and technical requirements.
In: Advances in Quantitative Coronary Arteriography. JHC Reiber, PW Serruys,
editors. Kluwer Academic Publishers, Dordrecht 1993: 75-111.
17. Beauman GJ, Reiber JHC, Koning G, Vogel RA.
Variability of QCA-core laboratory assessments of coronary anatomy.
In: Advances in Quantitative Coronary Arteriography. JHC Reiber, PW Serruys,
editors. Kluwer Academic Publishers, Dordrecht 1993: 137-59.
18. Zijlstra F, Boer MJ de, Hoorntje JCA, Reiber JHC, Suryapranata H.
Clinical and quantitative angiographic results of a randomized trial comparing
direct coronary angioplasty with intravenous streptokinase in acute myocardial
infarction.
In: Quantitative Coronary Angiography in Clinical Practice. PW Serruys, DP
Foley, PJ de Feyter, editors. Kluwer Academic Publishers, Dordrecht 1993: 38796.
19. Haase J, Nugteren SK, Montauban van Swijndregt E, Slager CJ, Di Mario C,
Feyter PJ de, Serruys PW.
Digital geometric measurements in comparison to cinefilm analysis of coronary
artery dimensions.
Cathet Cardiovasc Diagn 1993; 28: 283-90.
_____________________________________________________________________
QCA-CMS-References
2
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
20. Foley JB, Brown RIG, Penn IM.
Restenosis following elective implantation of single Palmaz-Schatz stents in denovo lesions in native vessels.
Coronary Artery Disease 1994; 5: 73-80.
21. Syvänne M, Nieminen MS, Frick MH.
Accuracy and precision of quantitative arteriography in the evaluation of coronary
artery disease after coronary bypass surgery.
Int J Cardiac Imaging 1994; 10: 243-52.
22. Ostojic M, Picano E, Beleslin B, Dordjevic-Dikic A, Distante A, Stepanovic J,
Reisenhofer B, Babic R, Stojkovic S, Nedeljkovic M, Stankovic G, Simeunovic
S, Kanjuh V.
Dipyridamole-dobutamine echocardiography: A novel test for the detection of
milder forms of coronary artery disease.
J Am Coll Cardiol 1994; 23: 1115-22.
23. Holmes Jr DR, Topol EJ, Adelman AG, Cohen EA, Califf RM.
Randomized trials of directional coronary atherectomy: implications for clinical
practice and future investigation.
J Am Coll Cardiol 1994; 24: 431-9.
24. Reiber JHC, Jukema W, Boven A van, Houdt RM van, Lie KI, Bruschke
AVG.
Catheter sizes for quantitative coronary arteriography.
Cathet Cardiovasc Diagn 1994; 33: 153-5.
25. Foley JB, Sridhar K, Dawdy J, Konstantinou C, Brown RIG, Penn IM.
Pros and cons of perfusion balloons in failed angioplasty.
Cathet Cardiovasc Diagn 1994; 31: 264-9.
26. Waters D, Higginson L, Gladstone P, Kimball B, Le May M, Boccuzzi SJ,
Lespérance J.
Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression
of coronary atherosclerosis as assessed by serial quantitative arteriography.
The Canadian Coronary Atherosclerosis Intervention Trial.
Circulation 1994; 89: 959-68.
27. Beleslin BD, Ostojic M, Stepanovic J, Djordjevic-Dikic A, Stojkovic S,
Nedeljkovic M, Stankovic G, Petrasinovic Z, Gojkovic L, Vasiljevic-Pokrajcic
Z, Nedeljkovic S.
Stress echocardiography in the detection of myocardial ischemia.
Circulation 1994; 90: 1168-76.
28. Foley JB, Brown RIG, Penn IM.
Thrombosis and restenosis after stenting in failed angioplasty: comparison with
elective stenting.
Am Heart J 1994; 128: 12-20.
29. Reiber JHC.
The Cineless catheterization laboratory.
Cardiologie 1994; 1: 369-76.
_____________________________________________________________________
QCA-CMS-References
3
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
30. Reiber JHC.
Why and how should QCA systems be validated?
In: Quantitative Coronary Angiography in Clinical Practice. PW Serruys, DP
Foley, PJ de Feyter, editors. Kluwer Academic Publishers, Dordrecht 1994: 1-6.
31. Reiber JHC, Koning G, Land CD von, Zwet PMJ van der.
Why and how should QCA systems be validated?
In: Progress in Quantitative Coronary Arteriography. JHC Reiber, PW Serruys,
editors. Kluwer Academic Publishers, Dordrecht 1994: 33-48.
32. Reiber JHC, Land CD von, Koning G, Zwet PMJ van der, Houdt RCM van,
Schalij MJ, Lespérance J.
Comparison of accuracy and precision of quantitative coronary arterial analysis
between cinefilm and digital systems.
In: Progress in Quantitative Coronary Arteriography. JHC Reiber, PW Serruys,
editors. Kluwer Academic Publishers, Dordrecht 1994: 67-85.
33. Beauman GJ, Reiber JHC, Koning G, Houdt RCM van, Vogel RA.
Angiographic core laboratory analyses of arterial phantom images: comparative
evaluations of accuracy and precision.
In: Progress in Quantitative Coronary Arteriography. JHC Reiber, PW Serruys,
editors. Kluwer Academic Publishers, Dordrecht 1994: 87-104.
34. Reiber JHC, Zwet PMJ van der, Koning G, Land CD von, Bosch JG,
Maurincomme E, Geest R van der, Gerbrands JJ.
Perspectieven in beeldvorming en beeldverwerking.
In: De toekomst van de cardiologie. FWA Verheugt, editor. Nederlandse
Hartstichting 1994: 63-91.
35. Boer MJ de, Reiber JHC, Suryapranata H, Brandt MJBM van den, Hoorntje
JCA, Zijlstra F.
Angiographic findings and catheterization laboratory events in patients with
primary coronary angioplasty or streptokinase therapy for acute myocardial
infarction.
Eur Heart J 1995; 16: 1347-55.
36. Zwet PMJ van der, Reiber JHC.
A new approach for the quantification of complex lesion morphology: The
Gradient Field Transform; Basic principles and validation results.
J Am Coll Cardiol 1994; 24: 216-24.
37. Nissen SE, Pepine CJ, Bashore TM, Block PC, Bonchek LI, Brinker JA, et al.
Cardiac angiography without cinefilm: Erecting a "Tower of Babel" in the cardiac
catheterization laboratory.
J Am Coll Cardiol 1994; 24: 834-7.
38. Reiber JHC, Koning G, Schiemanck LR, Zwet PMJ van der.
La place de l'informatique en cardiologie. Partie 10: Validation des systèmes ACQ,
finalités et modalités.
J Cardiol 1995; 7: 151-61.
_____________________________________________________________________
QCA-CMS-References
4
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
39. Reiber JHC, Koning G, Schiemanck LR, Zwet PMJ van der.
Computergebruik in de cardiologie. Deel 10: Validatie van QCA-systemen,
waarom en hoe?
Tijdschr Cardiol 1995; 7: 151-61.
40. Desmet W, De Scheerder I, Beatt K, Huehns T, Piessens J.
In vivo comparison of different quantitative edge detection systems used for
measuring coronary arterial diameters.
Cathet Cardiovasc Diagn 1995; 34: 72-80.
41. Reiber JHC (Editorial comment).
In vivo comparison of different quantitative edge detection systems used for
measuring coronary arterial diameters.
Cathet Cardiovasc Diagn 1995; 34: 81.
42. Foley JB.
Alterations in reference vessel diameter following intracoronary stent implantation:
important consequences for restenosis based on percent diameter stenosis.
Cathet Cardiovasc Diagn 1995; 35: 103-9.
43. Zwet PMJ van der, Reiber JHC (Editorial Comment).
Overestimation of small vessel sizes by QCA.
Cathet Cardiovasc Diagn 1995; 36: 25-6.
44. Moreu J, Silver MT, Palacios IF, Jang I-K.
Morphologic characteristics of restenotic lesions following coronary interventions:
Balloon angioplasty versus directional atherectomy: Can we speculate about the
mechanism of restenosis from morphologic analysis?
Cathet Cardiovasc Diagn 1995; 36: 103-9.
45. Faire U de, Ericsson C-G, Hamsten A, Nilsson J.
Design features of a five-year bezafibrate coronary atherosclerosis intervention trial
(BECAIT).
Drugs exptl clin res 1995; XXI(3): 105-24.
46. Keane D, Haase J, Slager CJ, Montauban van Swijndrecht E, Lehmann KG,
Ozaki Y, Mario C di, Kirkeeide R, Serruys PW.
Comparative validation of quantitative coronary angiography systems. Results and
implications from a multicenter study using a standardized approach.
Circulation 1995; 91: 2174-83.
47. Jukema JW, Bruschke AVG, Boven AJ van, Reiber JHC, Bal ET,
Zwinderman AH, Jansen H, Boerma GJM, Rappard FM van, Lie KI.
Effects of lipid lowering by pravastatin on progression and regression of coronary
artery disease in symptomatic men with normal to moderately elevated serum
cholesterol levels. The regression growth evaluation statin study (REGRESS).
Circulation 1995; 91: 2528-40.
48. Reiber JHC, Schiemanck LR, Zwet PMJ van der, Koning G, Goedhart B,
Gerbrands JJ, Schalij MJ, Bruschke AVG.
Evolution of quantitative coronary arteriography.
In: Advances in Imaging Techniques in Ischemic Heart Disease. EE van der Wall,
TH Marwick, JHC Reiber, editors. Kluwer Academic Publishers, Dordrecht 1995:
139-52.
_____________________________________________________________________
QCA-CMS-References
5
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
49. Zwet PMJ van der, Meyer DJH, Reiber JHC.
Automated and accurate assessment of the distribution, magnitude and direction of
pincushion distortion in angiographic images.
Investigative Radiology 1995; 4: 204-13.
50. Hausleiter J, Nolte CWT, Jost S, Wiese B, Sturm M, Lichtlen PR.
Comparison of different quantitative coronary analysis systems: ARTREK, CAAS
and CMS.
Cathet Cardiovasc Diagn 1996; 37: 14-22.
51. Reiber JHC (Editorial Comment).
Cathet Cardiovasc Diagn 1996; 37: 23.
52. Beauman GJ, Reiber JHC, Koning G, Vogel RA.
Comparisons of angiographic core laboratory analyses of phantom and clinical
images: Interlaboratory Variability.
Cathet Cardiovasc Diagn 1996; 37: 24-31.
53. Reiber JHC, Koning G, Zwet PMJ van der, Schiemanck LR.
Inaccuracy of quantitative coronary angiography when analyzed from S-VHS
videotape.
Cathet Cardiovasc Diagn 1996; 37: 32-8.
54. Legrand V, Raskinet B, Martinez C, Kulbertus H.
Variability in estimation of coronary dimensions from 6F and 8F catheters.
Cathet Cardiovasc Diagn 1996; 37: 39-45.
55. Reiber JHC (Editorial Comment).
Cathet Cardiovasc Diagn 1996; 37: 46.
56. Jukema JW, Boven AJ van, Reiber JHC, Zwinderman AH, Lie KI, Bruschke
AVG.
Clinical efficacy and safety of pravastatin treatment in symptomatic patients - the
REGRESS trial.
In: Lipid-lowering therapy and progression of coronary atherosclerosis. AVG
Bruschke, JHC Reiber, KI Lie, HJJ Wellens, editors. Kluwer Academic Publishers,
Dordrecht 1996: 85-106.
57. Reiber JHC, Jukema JW, Koning G, Bruschke AVG.
Quality control in quantitative coronary arteriography.
In: Lipid-lowering therapy and progression of coronary atherosclerosis. AVG
Bruschke, JHC Reiber, KI Lie, HJJ Wellens, editors. Kluwer Academic Publishers,
Dordrecht 1996: 45-63.
58. Kimball BP, Cohen EA, Adelman AG.
Influence of stenotic lesion morphology on immediate and long-term (6 months)
angiographic outcome: comparative analysis of directional coronary atherectomy
versus standard balloon angioplasty.
J Am Coll Cardiol 1996; 27: 543-51.
59. Suryapranata H, Zijlstra F, Hoorntje JCA, Boer MJ de.
Primary angioplasty in the management of patients with acute myocardial
infarction.
The Thoraxcentre Journal 1996; 8: 9-17.
_____________________________________________________________________
QCA-CMS-References
6
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
60. Tresukosol D, Schalij MJ, Savalle LH, Jukema JW, Buis B, Reiber JHC,
Bruschke AVG.
Micro Stent™, quantitative coronary angiography, and procedural results.
Cathet Cardiovasc Diagn 1996; 38: 135-43.
61. Natarajan MK, Bowman KA, Chrisholm RJ, Adelman AG, Isner JM,
Chokshi SK, Strauss BH.
Excimer laser angiography vs. balloon angioplasty in saphenous vein bypass grafts:
Quantitative angiographic comparison of matched lesions.
Cathet Cardiovasc Diagn 1996; 38: 153-58.
62. Hong MK, Mintz GS, Popma JJ, Kent KM, Pichard AD, Satler LF, Wong SC,
Bucher T, Leon MB.
Angiographic results and late clinical outcomes utilizing a stent synergy (pre-stent
atheroablation) approach in complex lesion subsets.
J Invas Cardiol 1996; 8: 15-22.
63. Satler LF, Hoffman R, Lansky A, Mintz GS, Popma JJ, Pichard AD, Kent
KM, Hong MK, Korzak N, Horton K, Cabellion S, Leon MB.
Carotid stent - Assisted angioplasty: preliminary technique, angiography, and
intravascular ultrasound observations.
J Invas Cardiol 1996; 8: 23-30.
64. Hausleiter J, Dirschinger J, Kreis A, Schömig A.
The role of image distortion in quantitative coronary arteriography.
Abstract book 1996 International Symposium on Cardiovascular Imaging; Leiden,
The Netherlands, June 24-26, 1996: 70.
65. Reiber JHC, Schiemanck LR, Zwet PMJ van der, Goedhart B, Koning G,
Lammertsma M, Danse MH, Gerbrands JJ, Schalij MJ, Bruschke AVG.
State of the art in quantitative coronary arteriography as of 1996.
In: Cardiovascular Imaging. JHC Reiber, EE van der Wall, editors. Kluwer Academic
Publishers, Dordrecht 1996: 39-56.
66. Cusma JT, Bashore TM.
The digital catheterization laboratory - is it practical today?
In: Cardiovascular Imaging. JHC Reiber, EE van der Wall, editors. Kluwer Academic
Publishers, Dordrecht 1996: 157-70.
67. Goedhart B, Reiber JHC.
The role of DICOM in the digital catheterization laboratory.
In: Cardiovascular Imaging. JHC Reiber, EE van der Wall, editors. Kluwer Academic
Publishers, Dordrecht 1996: 171-84.
68. Bourassa MG, Lespérance J.
Assessing coronary stenosis: by which method and for what purpose?
Eur Heart J 1996; 17: 1137-8.
69. Gottsauner-Wolf M, Sochor H, Moertl D, Gwechenberger M, Stockenhuber
F, Probst P.
Assessing coronary stenosis. Quantitative coronary angiography versus visual
estimation from cine-film or pharmacological stress perfusion images.
Eur Heart J 1996; 17: 1167-74.
_____________________________________________________________________
QCA-CMS-References
7
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
70. Mongiardo R, Finocchiaro ML, Beltrame J, Pristipino C, Lombardo A,
Cianflone D, Mazzari MA, Maseri A.
Low incidence of serotin-induced occlusive coronary artery spasm in patients with
recent myocardial infarction.
Am J Cardiol 1996; 78: 84-7.
71. Hong MK, Mintz GS, Popma JJ, Kent KM, Pichard AD, Satler LF, Wong C,
Brahimi A, Bucher T, Leon MB.
Safety and efficacy of elective stent implantation following atherectomy in large
calcified coronary arteries.
Cathet Cardiovasc Diagn 1996; 3: 50-4.
72. Veen G, Cock C de, Verheugt FWA.
Quantative assessment of remodelling of culprit coronary lesions after succesful
thrombolysis for acute myocardial infarction.
In: Angiographic aspects of reperfusion therapy for acute myocardial infarction.
G Veen, Thesis Free University of Amsterdam 1996; Ch. 4: 75-110.
73. Veen G, Boer M-J de, Zijlstra F, Verheugt FWA.
Major improvement in clinical and angiographic outcome after successful primary
angioplasty for acute myocardial infarction: comparison with succesful
thrombolysis.
In: Angiographic aspects of reperfusion therapy for acute myocardial infarction.
G Veen, Thesis Free University of Amsterdam 1996; Ch. 7: 155-75.
74. Robert N, Yaffe MJ, Langer A.
Variations in measured vessel diameters using coronary measurement system.
Cathet Cardiovasc Diagn 1996; 39: 131-6.
75. El Setiha M, El Gamal M, Koolen J, Pijls N, Bonnier H, Michels R.
Coronary stenting for failed angioplasty in acute myocardial infarction.
Cathet Cardiovasc Diagn 1996; 39: 149-54.
76. Reiber JHC.
QCA and cine film exposure: Editorial Comment.
Cathet Cardiovasc Diagn 1996; 39: 137.
77. Lespérance J, Campeau L, Reiber JHC, Bois M, Dyrda I, Laurier J, Hudon
G.
Validation of coronary artery saphenous vein bypass graft diameter measurements
using quantitative angiography.
Int J Cardiac Imaging 1996; 12: 299-303.
78. Chen L, Théroux P, Lespérance J, Shabani F, Thibault B, Guise P de.
Angiographic features of vein grafts versus ungrafted coronary arteries in patients
with unstable angina and previous bypass surgery.
J Am Coll Cardiol 1996; 28: 1493-9.
79. Djordjevic-Dikic AD, Ostojic MC, Beleslin BD, Stepanovic J, Petrasinovic Z,
Babic R, Stojkovic SM, Stankovic G, Nedeljkovic M, Nedeljkovic I, Kanjuh V.
High dose adenosine stress echocardiography for noninvasive detection of coronary
artery disease.
J Am Coll Cardiol 1996; 28: 1689-95.
_____________________________________________________________________
QCA-CMS-References
8
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
80. Haude M, Caspari G, Baumgart D, Brennecke R, Meyer J, Erbel R.
Comparison of myocardial perfusion reserve before and after coronary balloon
predilatation and after stent implantation in patients with postangioplasty
restenosis.
Circulation, 1996; 94: 286-97.
81. Faire U de, Ericsson C-G, Grip L, Nilsson J, Svane B, Hamsten A.
Secondary preventive potential of lipid-lowering drugs.
The Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT).
Eur Heart J 1996; 17 (Suppl F): 37-42.
82. Satler LF, Hoffmann R, Lansky A, Mintz GS, Popma JJ, Pichard AD, Kent
MK, Hong MK, Korzak N, Horton K, Cabellion S, Leon MB.
Carotid stent - assisted angioplasty: Preliminary technique, angiography, and
intravascular ultrasound observations.
J Invas Cardiol 1996; 8: 23-30.
83. Hong MK, Mintz GS, Popma JJ, Kent KM, Pichard AD, Satler LF, Wong SC,
Bucher T, Leon MB.
Angiographic results and late clinical outcomes utilizing a stent synergy (pre-stent
atheroablation) approach in complex lesion subsets.
J Invas Cardiol 1996; 8: 15-22.
84. Ericsson C-G, Hamsten A, Nilsson J, Grip L, Svane B, Faire U de.
Angiographic assessment of effects of bezafibrate on progression of coronary
artery disease in young male postinfarction patients.
Lancet 1996; 347: 849-53.
85. Grip L, Blombäck M, Egberg N, Olsson A, Svane B, Velander M.
Antithrombin III supplementation for patients undergoing PTCA for unstable
angina pectoris. A controlled randomize double-blind pilot study.
Eur Heart J 1997; 18: 443-9.
86. Lupi A, Buffon A, Finocchiaro ML, Conti E, Maseri A, Crea F.
Mechanisms of adenosine-induced epicardial coronary artery dilatation.
Eur Heart J 1997; 18: 614-7.
87. Reimers B, Di Mario C, Di Francesco L, Moussa I, Blengino S, Martini G,
Reiber JHC, Colombo A.
New approach to quantitative angiographic assessment after stent implantation.
Cathet Cardiovasc Diagn; 1997; 40: 343-7.
88. Boer MJ de, Zijlstra F.
Coronary angioplasty in myocardial infarction.
In: Practical Interventional Cardiology. ED Grech, DR Ramsdale, editors. Martin
Dunitz, London, 1997: 123-40.
89. Beleslin BD, Ostojic M, Djordjevic-Dikic A, Nedeljkovic M, Stankovic G,
Stojkovic S, Babic R, Stepanovic J, Saponjski J, Marinkovic J, VasiljevicPokrajcic Z, Kanjuh V.
Coronary vasodilation without myocardial erection. Simultaneous haemodynamic,
echocardiographic and arteriographic findings during adenosine and dipyridamole
infusion.
Eur Heart J 1997; 18: 1166-74.
_____________________________________________________________________
QCA-CMS-References
9
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
90. Glazier JJ, Hirst JA, Kiernan FJ, Fram DB, Eldin AM, Primiano CA, Mitchel
JF, McKay RG.
Site-specific intracoronary thrombolysis with urokinase-coated hydrogel balloons:
acute and follow-up studies in 95 patients.
Cathet Cardiovasc Diagn; 1997; 41: 246-53.
91. Glazier JJ, Kiernan FJ, Bauer HH, Fram DB, Primiano CA, Mitchel JF,
Dougherty JE, McKay RG.
Treatment of thrombotic saphenous vein bypass grafts using local urokinase
infusion therapy with the dispatch catheter.
Cathet Cardiovasc Diagn; 1997; 41: 261-7.
92. Baumgart D, Schmermund A, Goerge G, Haude M, GE J, Adamzik M,
Sehnert C, Altmaier K, Groenemeyer D, Seibel R, Erbel R.
Comparison of electron beam computed tomography with intracoronary ultrasound
and coronary angiography for detection of coronary atherosclerosis.
J Am Coll Cardiol; 1997; 30: 57-64.
93. Reimers B, Moussa I, Akiyama T, Tucci G, Ferraro M, Martini G, Blengino S,
Di Mario C, Colombo A.
Long-term clinical follow-up after successful repeat percutaneous intervention for
stent restenosis.
J Am Coll Cardiol; 1997; 30: 186-92.
94. Baur LHB, Schipperheyn JJ, Wall EE van der, Velde EA van der, Schalij
MJ, Eck-Smit BLF van, Laarse A van der, Voogd PJ, Sedney MI, Reiber
JHC, Bruschke AVG.
Beneficial effect of enalapril on left ventricular remodelling in patients with a
severe residual stenosis after acute anterior wall infarction.
Eur Heart J 1997; 18: 1313-21.
95. Tardif J-C, Côté G, Lespérance J, Bourassa M, Lambert J, Doucet S,
Bilodeau L, Nattel S, Guise P de.
Probucol and multivitamins in the prevention of restenosis after coronary
angioplasty.
N Eng J Med 1997; 337: 365-72.
96. Dietz U, Rupprecht H-J, Brennecke R, Fritsch H-P, Woltmann J,
Blankenberg S, Meyer J.
Comparison of QCA systems.
Int J Cardiac Imaging 1997; 13: 271-80.
97. Pajunen P, Nieminen MS, Taskinen M-R, Syvänne M.
Quantitative comparison of angiographic characteristics of coronary artery disease
in patients with noninsulin-dependent diabetes mellitus compared with matched
nondiabetic control subjects.
Am J Cardiol 1997; 80: 550-6.
98. Schalij MJ, Savalle LH, Tresukosol D, Jukema JW, Reiber JHC.
Micro Stent I, initial results, and six months follow-up by quantitative coronary
angiography.
Cathet and Cardiovasc Diagn 1998; 43: 19-27.
_____________________________________________________________________
QCA-CMS-References
10
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
99. Akasaka T, Yoshida K, Hozumi T, Takagi T, Kaji S, Kawamoto T, Morioka
S, Yoshikawa J.
Retinopathy identifies marked restriction of coronary flow reserve in patients with
diabetes mellitus.
J Am Coll Cardiol 1997; 30: 935-41.
100. Reiber JHC, Goedhart B, Brand G-J, Schiemanck L.
Quantitative coronary arteriography: current status and future.
Heart Vessels 1997; S12: 209-11.
101. Kastrati A, Schömig A, Elezi S, Schühlen H, Dirschinger J, Hadamitzky M,
Wehinger A, Hausleiter J, Walter H, Neumann F-J.
Predictive factors of restenosis after coronary stent placement.
J Am Coll Cardiol 1997; 30: 1428-36.
102. Cobbaert C, Jukema JW, Zwinderman AH, Withagen AJAM, Lindemans J,
Bruschke AVG.
Modulation of lipoprotein(a) atherogenicity by high density lipoprotein cholesterol
levels in middle-aged men with symptomatic coronary artery disease and normal
to moderately elevated serum cholesterol.
J Am Coll Cardiol 1997; 30: 1491-9.
103. Tardif J-C, Côté G, Lespérance J, Bourassa M, Lambert J, Doucet S,
Bilodeau L, Nattel S, de Guise P, for the Multivitamins and Probucol Study
Group.
Probucol and multivitamins in the prevention of restenosis after coronary
angioplasty.
N Eng J Med; 337: 365-72.
104. Schmermund A, Baumgart D, Görge G, Grönemeyer D, Seibel R, Bailey KR,
Rumberger JA, Paar D, Erbel R.
Measuring the effect of risk factors on coronary atherosclerosis: coronary calcium
score versus angiographic disease severity.
J Am Coll Cardiol 1998; 28: 1267-73.
105. Yasuda H, Hiraishi T, Sumitsuji S, Nakagawa Y, Fukuhara A, Tsuchikane E,
Katoh O, Awata N, Kobayashi T.
Comparison of quantitative coronary angiographic results after directional coronary
atherectomy and balloon angioplasty of protected left main coronary stenosis.
Cathet Cardiovasc Diagn; 1998; 44: 138-41.
106. McLaughlin PR, Gladstone P, for the DAIS Project Group
Diabetes atherosclerosis intervention study (DAIS): Quantitative coronary
angiograpic analysis of coronary artery atherosclerosis.
Cathet Cardiovasc Diagn; 1998; 44: 249-56.
107. Cannan CR, Kaplan AV, Klein EJ, Galant P, Sharaf BL, Williams DO.
Novel perfusion sleeve for use during balloon angioplasty: Initial clinical
experience.
Cathet Cardiovasc Diagn; 1998; 44: 358-62.
_____________________________________________________________________
QCA-CMS-References
11
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
108. Gregorio J de, Kobayashi Y, Albiero R, Reimers B, Di Mario C, Finci L,
Colombo A.
Coronary artery stenting in the elderly: Short-term outcome and long-term
angiographic and clinical follow-up.
J Am Coll Cardiol 1998; 32, (3): 577-83.
109. Abizaid A, Kornowski R, Mintz GS, Hong MK, Abizaid AS, Mehran R,
Pichard AD, Kent KM, Satler LF, Wu H, Popma JJ, Leon MB.
The influence of diabetes mellitus on acute and late clinical outcomes following
coronary stent implantation.
J Am Coll Cardiol 1998; 32, (3): 584-9.
110. Kobayashi Y, Moussa I, Akiyama T, Reimers B, Di Mario C, Finci L,
Colombo A.
Low restenosis rate in lesions of the left anterior descending coronary artery with
stenting following directional coronary atherectomy.
Cathet Cardiovasc Diagn 1998; 45: 131-8.
111. Kastrati A, Neumann F-J, Schömig A.
Operator volume and outcome of patients undergoing coronary stent placement.
J Am Coll Cardiol 1998; 32 (4): 970-6.
112. Rodriguez A, Ayala F, Bernardi V, Santaera O, Marchand E, Pardinas C,
Mauvecin C, Vogel D, Harrell LC, Palacios IF.
Optimal coronary balloon angioplasty with provisional stenting versus primary
stent (OCBAS). Immediate and long-term follow-up results.
J Am Coll Cardiol 1998; 32 (5): 1351-7.
113. Akiyama
T, Moussa I, Reimers B, Ferraro M, Kobayashi Y, Blengino S,
Di Francesco L, Finci L, Di Mario C, Colombo A.
Angiographic and clinical outcome following coronary stenting of small vessels. A
comparion with coronary stenting of large vessels.
J Am Coll Cardiol 1998; 32 (6): 1610-8.
114. Ruotolo G, Ericsson C-G, Tettamanti C, Karpe F, Grip L, Svane B, Nilsson J,
De Faire U, Hamsten A.
Treatment effects on serum lipoprotein lipids, apolipoproteins and low density
lipoprotein particle size and relationships of lipoprotein variables to progression of
coronary artery disease in the bezafibrate coronary atherosclerosis intervention trial
(BECAIT).
J Am Coll Cardiol 1998; 32 (6): 1648-56.
115. Elezi S, Kastrati A, Pache J, Wehinger A, Hadamitzky M, Dirschinger J,
Neumann F-J, Schömig A.
Diabetes mellitus and the clinical and angiographic outcome after coronary stent
placement.
J Am Coll Cardiol 1998; 32 (7): 1866-73.
116. Akasaka T, Yoshida K, Hozumi T, Takagi T, Kaji S, Kawamoto T, Ueda Y,
Okada Y, Morioka S, Yoshikawa J.
Restricted coronary flow reserve in patients with mitral regurgitation improves
after mitral reconstructive surgery.
J Am Coll Cardiol 1998; 32 (7): 1923-30.
_____________________________________________________________________
QCA-CMS-References
12
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
117. Caramori PRA, Adelman AG, Azevedo ER, Newton GE, Parker AB, Parker
JD.
Therapy with nitroglycerin increases coronary vasoconstriction in response to
acetylcholine.
J Am Coll Cardiol 1998; 32 (7): 1969-74.
118. Jeremias A, Görge G, Konorza T, Haude M, Birgelen C von, Ge J, Simon H,
Erbel R.
Stepwise intravascular ultrasound (IVUS) guidance of high-pressure coronary
stenting does not result in an improved acute or long-term outcome: A randomized
comparison to ‘final-look’ IVUS assessment.
Cathet Cardiovasc Interventions 1999; 46: 135-4.
119. Kastrati A, Schömig A, Seyfarth M, Koch W, Elezi S, Böttiger C, Mehilli J,
Schömig K, Beckerath N von.
PlA Polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary
stent placement.
Circulation 1999; 99: 1005-10.
120. Hanekamp CEE, Koolen JJ, Pijls NHJ, Michels HR, Bonnier HJRM.
Comparison of quantitative coronary angiography, intravascular ultrasound, and
coronary pressure measurement to assess optimum stent deployment.
Circulation 1999; 99: 1015-21.
121. Kobayashi Y, De Gregorio J, Kobayashi N, Akiyama T, Reimers
B,
Moussa I, Di Mario C, Finci L, Colombo A.
Lower restenosis rate with stenting following aggressive versus less aggressive
rotational atherectomy.
Cathet Cardiovasc Interventions 1999; 46: 406-14.
122. Prasad N, Ali H, Schwartz L.
Short- and long-term outcome of balloon angioplasty for compromised side
branches after intracoronary stent deployment.
Cathet Cardiovasc Interventions 1999; 46: 421-4.
123. Beleslin BD, Ostojic M, Djordjevic-Dikic A, Babic R, Nedeljkovic M,
Stankovic G, Stojkovic S, Marinkovic J, Nedeljkovic I, Stepanovic J,
Saponjski J, Petrasinovic Z, Nedeljkovic S, Kanjuh V.
Integrated evaluation of relation between coronary lesion features and stress
echocardiography results: The importance of coronary lesion morphology.
J Am Coll Cardiol 1999; 33 (3): 717-26.
124. Ledru F, Théroux P, Lespérance J, Laurier J, Ducimetière P, Guermonprez JL, Diébold B, Blanchard D.
Geometric features of coronary artery lesions favoring acute occlusion and
myocardial infarction: a quantitative angiographic study.
J Am Coll Cardiol 1999; 33 (5): 1353-61.
125. Sakamoto T, Kawarabayashi T, Taguchi H, Tanaka A, Nishida Y, Shimada
K, Yoshikawa J.
Intravascular ultrasound-guided balloon angioplasty for treatment of in-stent
restenosis.
Cathet Cardiovasc Interventions 1999; 47: 298-303.
_____________________________________________________________________
QCA-CMS-References
13
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
126. Von Birgelen C, Haude M, Herrmann J, Altmann C, Klinkhart W, Welge D,
Wieneke H, Baumgart D, Sack S, Erbel R.
Early clinical experience with the implantation of a novel synthetic coronary stent
graft.
Cathet Cardiovasc Interventions 1999; 47: 496-503.
127. Schunkert H, Harrell L, Palacios IF.
Implications of small reference vessel diameter in patients undergoing
percutaneous coronary revascularization.
J Am Coll Cardiol 1999; 34 (1): 40-8.
128. Abizaid AS, Sousa A, Centemero M, Abizaid A, Chaves A, Tanajura LF,
Seixas AC, Sousa JE.
Twenty-year follow-up after percutaneous transluminal coronary angioplasty.
Am J Cardiol 1999; 84 (6A): 24P (Abstract).
129. Reiber JHC, Goedhart B, Dijkstra J, Koning G, Oemrawsingh PV, Jukema
JW, Geest RJ van der.
Future of computerized analysis of vascular images.
In: Computer-Aided Diagnosis in Medical Imaging. K Doi, H MacMahon, ML
Giger, KR Hoffmann, editors. Elsevier Science Ltd., Oxford 1999: 319-31.
130. Abizaid AS, Mintz GS, Abizaid A, Mehran R, Lansky AJ, Pichard AD, Satler
LF, Wu H, Kent KM, Leon MB.
One-year follow-up after intravascular ultrasound assessment of moderate left main
coronary artery disease in patients with ambiguous angiograms.
J Am Coll Cardiol 1999; 34 (3): 707-15.
131. Schömig A, Kastrati A, Elezi S, Schühlen H, Dirschinger J, Dannegger F,
Wilhelm M, Ulm K.
Bimodal distribution of angiographic measures of restenosis six months after
coronary stent placement.
Circulation 1997; 96: 3880-7.
132. Kobayashi Y, Gregorio J De, Kobayashi N, Akiyama T, Reimers B, Finci L,
Di Mario C.
Stented segment length as an independent predictor of restenosis.
J Am Coll Cardiol 1999; 34 (3): 651-9.
133. Elezi S, Kastrati A, Hadamitzky M, Dirschinger J, Neumann F-J, Schömig A.
Clinical and angiographic follow-up after balloon angioplasty with provisional
stenting for coronary in-stent restenosis.
Cathet Cardiovasc Interventions 1999; 48: 151-6.
134. Harrell L, Schunkert H, Palacios IF.
Risk predictors in patients scheduled for percutaneous coronary revascularization.
Cathet Cardiovasc Interventions 1999; 48: 253-60.
135. Moreno PR, Fallon JT, Murcia AM, Leon MN, Simosa H, Fuster V, Palacios
IF.
Tissue characteristics of restenosis after percutaneous transluminal coronary
angioplasty in diabetic patients.
J Am Coll Cardiol 1999; 34 (4): 1045-9.
_____________________________________________________________________
QCA-CMS-References
14
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
136. Tsuchikane E, Sumitsuji S, Awata N, Nakamura T, Kobayashi T, Izumi M,
Otsuji S, Tateyama H, Sakurai M, Kobayashi T.
Final results of the stent versus directional coronary atherectomy randomized trial
(START).
J Am Coll Cardiol 1999; 34 (4): 1050-7.
137. Lansky AJ, Popma JJ, Cutlip D, Ho KKL, Abizaid AS, Saucedo J, Zhang Y,
Senerchia C, Kuntz RE, Leon MB, Baim DS, for the BOAT Investigators.
Comparative analysis of early and late angiographic outcomes using two
quantitative algorithms in the balloon versus optimal atherectomy trial (BOAT).
Am J Cardiol 1999; 83: 1611-6.
138. Lansky AJ, Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Baim DS,
Kuntz RE, Simonton C, Bersin RM, Hinohara T, Fitzgerald PJ, Leon MB.
Remodeling after directional coronary atherectomy (with and without adjunct
percutaneous transluminal coronary angioplasty): a serial angiographic and
intravascular ultrasound analysis from the optimal atherectomy restenosis study.
J Am Coll Cardiol 1998; 32 (2): 329-37.
139. Baim DS, Cutlip DE, Sharma SK, Ho KKL, Fortuna R, Schreiber TL,
Feldman RL, Shani J, Senerchia C, Zhang Y, Lansky AJ, Popma JJ, Kuntz
RE, for the BOAT Investigators.
Final results of the balloon vs optimal atherectomy trial (BOAT).
Circulation 1998; 97: 322-31.
140. Simonton CA, Leon MB, Baim DS, Hinohara T, Kent KM, Bersin RM,
Wilson BH, Mintz GS, Fitzgerald PJ, Yock PG, Popma JJ, Ho KKL, Cutlip
DE, Senerchia C, Kuntz RE.
’Optimal’ directional coronary atherectomy. Final results of the optimal
atherectomy restenosis study (OARS).
Circulation 1998; 97: 332-9.
141. Buffon A, Liuzzo G, Biasucci LM, Pasqualetti P, Ramazzotti V, Rebuzzi AG,
Crea F, Maseri A.
Preprocedural serum levels of C-reactive protein predict early complications and
late restenosis after coronary angioplasty.
J Am Coll Cardiol 1999; 34 (5): 1512-21.
142. Popma JJ, Lansky AJ, Yeh W, Kennard ED, Keller MB, Merritt AJ, DeFalco
RA, Desai A, Pacera JH, Schnabel JF, Niedermeyer V, Baim DS, Detre KM
for the NACI Investigators.
Reliability of the quantitative angiographic measurements in the new approaches to
coronary intervention (NACI) Registry: A comparison of clinical site and repeated
angiographic core laboratory readings.
Am J Cardiol 1997; 80 (10A): 19K-25K.
143. Knight CJ, Curzen NP, Groves PH, Patel DJ, Goodall AH, Wright C, Clarke
D, Oldershaw PJ, Fox KM.
Stent implantation reduces restenosis in patients with suboptimal results following
coronary angioplasty.
Eur Heart J 1999; 20: 1783-90.
_____________________________________________________________________
QCA-CMS-References
15
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
144. Caramori PRA, Lima VC, Seidelin PH, Newton GE, Parker JD, Adelman AG.
Long-term endothelial dysfunction after coronary artery stenting.
J Am Coll Cardiol 1999; 34 (6): 1675-9.
145. Liebergen RAM van, Piek JJ, Koch KT, Peters RJG, Winter RJ de,
Schotborgh CE, Lie KI.
Hyperemic coronary flow after optimized intravascular ultrasound-guided balloon
angioplasty and stent implantation.
J Am Coll Cardiol 1999; 34 (7): 1899-906.
146. Kini A, Marmur JD, Dangas G, Choudhary S, Sharma SK.
Angiographic patterns of in-stent restenosis and implications on subsequent
revascularization.
Cathet Cardiovasc Interventions 2000; 49: 23-9.
147. Hozumi T, Yoshida K, Akasaka T, Asami Y, Kanzaki Y, Ueda Y, Yamamuro
A, Takagi T, Yoshikawa J.
Value of acceleration flow and the prestenotic to stenotic coronary flow velocity
ratio by transthoracic color Doppler echocardiography in noninvasive diagnosis of
restenosis after percutaneous transluminal coronary angioplasty.
J Am Coll Cardiol 2000; 35 (1): 164-8.
148. Tuinenburg JC, Koning G, Hekking E, Zwinderman AH, Becker T, Simon R,
Reiber JHC.
American College of Cardiology/European Society of Cardiology international
study of angiographic data compression phase II. The effects of varying JPEG data
compression levels on the quantitative assessment of the degree of stenosis in
digital coronary angiography.
Eur Heart J 2000; 21: 679-86.
149. Ruotolo G, Bavenholm P, Brismar K, Eféndic S, Ericsson C-G, De Faire U,
Nilsson J, Hamsten A.
Serum Insulin-like growth factor-I level is Independently associated with coronary
artery disease progression in young male survivors of myocardial infarction:
beneficial effects of bezafibrate treatment.
J Am Coll Cardiol 2000; 35 (3): 647-54.
150. Neumann F-J, Kastrati A, Schmitt C, Blasini R, Hadamitzky M, Mehilli J,
Gawaz M, Schleef M, Seyfarth M, Dirschinger J, Schömig A.
Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and
angiographic restenosis rate after the placement of coronary stents following acute
myocardial infarction.
J Am Coll Cardiol 2000; 35 (4): 915-21.
151. Teirstein PS, Massullo V, Jani S, Popma JJ, Russo RJ, Schatz RA, Guarneri
EM, Steuterman S, Sirkin K, Cloutier DA, Leon MB, Tripuraneni P.
Three-year clinical and angiographic follow-up after intracoronary radiation.
Results of a randomized clinical trial.
Circulation 2000; 101: 360-65.
152. Yamashita T, Nishida T, Adamian MG, Briguori C, Vaghetti M, Corvaja N,
Albiero R, Finci L, Di Mario C, Tobis JM, Colombo A.
Bifurcation lesions: two stents versus one stent – Immediate and follow-up results.
J Am Coll Cardiol 2000; 35 (5): 1145-51.
_____________________________________________________________________
QCA-CMS-References
16
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
153. Gyöngyösi M, Yang P, Khorsand A, Glogar G, on behalf of the Austrian
Wiktor Stent Study Group and European Paragon Stent Investigators.
Longitudinal straightening effect of stents is an additional predictor for major
adverse cardiac events.
J Am Coll Cardiol 2000; 35 (6): 1580-9.
154. Gottsauner-Wolf M, Zasmeta G, Hornykewycz S, Nikfardjam M, Stepan E,
Wexberg P, Zorn G, Glogar D, Probst P, Maurer G, Huber K.
Plasma levels of C-reactive protein after coronary stent implantation.
Eur Heart J 2000; 21: 1152-8.
155. Dauerman HL, Prpic R, Andreou C, Vu MA, Popma JJ.
Angiographic and clinical outcomes after rescue coronary stenting.
Cathet Cardiovasc Interventions 2000; 50: 269-75.
156. Kastrati A, Dirschinger J, Boekstegers P, Elezi S, Schuehlen H, Pache J,
Steinbeck G, Schmitt C, Ulm K, Neumann F-J, Schoemig A.
Influence of stent design on 1-year outcome after coronary stent placement: a
randomized comparison of five stent types in 1,147 unselected patients.
Cathet Cardiovasc Interventions 2000; 50: 290-7.
157. Moer R, Myreng Y, Molstad P, Ytre-Arne K, Sirnes PA, Golf S.
Stenting small coronary arteries using two second-generation slotted tube stents:
acute and six-month clinical and angiographic results.
Cathet Cardiovasc Interventions 2000; 50: 307-13.
158. Briguori C, Nishida T, Adamian M, Di Mario C, Moses J, Colombo A.
Multivessel coronary stenting: predictors of early and late outcome.
Ital. Heart J 2000; 1 (6): 420-5.
159. Briguori C, Nishida T, Adamian M, Albiero R, Anzuini A, Di Mario C,
Colombo A.
Coronary stenting versus balloon angioplasty in small coronary artery with
complex lesions.
Cathet Cardiovasc Interventions 2000; 50: 390-7.
160. Ormiston JA, Webster MWI, Ruygrok PN, Elliott JM, Simmonds MB,
Meredith IT, Devlin GP, Stewart JT, Dixon SR, Price S, Ellis CJ, West TM,
on behalf of the NIR Future Trial Investigators
A randomized study of direct coronary stent delivery compared with stenting after
predilatation: the NIR Future Trial.
Cathet Cardiovasc Interventions 2000; 50: 377-81.
161. Briguori C, Nishida T, Adamian M, Albiero R, Anzuini A, Di Mario C,
Colombo A.
Coronary stenting versus balloon angioplasty in small coronary artery with
complex lesions.
Cathet Cardiovasc Interventions 2000; 50: 390-97.
162. Kastrati A, Koch W, Gawaz M, Mehilli J, Böttiger C, Schömig K, Beckerath
N von, Schömig A.
P1A polymorphism of Glycoprotein IIIa and risk of adverse events after coronary
stent placement.
J Am Coll Cardiol 2000; 36 (1): 84-9.
_____________________________________________________________________
QCA-CMS-References
17
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
163. Weert AWM van, Lésperance J, Reiber JHC.
Standardization of central off-line quantitative image analysis: implications from
experiences with quantitative coronary angiography.
Heart Drug 2000; 1: 44-51.
164. Carter AJ, Lee DP, Suzuki T, Bailey L, Lansky A, Jones R, Virmani R.
Experimental evaluation of a short transitional edge protection balloon for
intracoronary stent deployment.
Cath and Cardiovasc Interventions 2000; 51: 112-9.
165. Velianou JL, Strauss BH, Kreatsoulas C, Pericak D, Natarajan MK.
Evaluation of the role of Abciximab (Reopro) as a rescue agent during
percutaneous coronary interventions: in-hospital and six-month outcomes.
Cath and Cardiovasc Interventions 2000; 51: 138-44.
166. Ahmed JM, Hong MK, Mehran R, Dangas G, Mintz GS, Pichard AD,
Satler LF, Kent KM, Wu H, Stone GW, Leon MB.
Influence of diabetes mellitus on early and late clinical outcomes in saphenous vein
graft stenting.
J Am Coll Cardiol 2000; 36 (4): 1186-93.
167. Takagi T, Akasaka T, Yamamuro A, Honda Y, Hozumi T, Morioka S,
Yoshida K.
Troglitazone reduces neointimal tissue proliferation after coronary stent
implantation in patients with non-insulin dependent diabetes mellitus.
J Am Coll Cardiol 2000; 36 (5): 1529-35.
168. Gruberg L, Mintz GS, Mehran R, Dangas G, Lansky AJ, Kent KM,
Pichard AD, Satler LF, Leon MB.
The prognostic implications of further renal function deterioration within 48 h of
interventional coronary procedures in patients with pre-existent chronic renal
insufficiency.
J Am Coll Cardiol 2000; 36 (5): 1542-8.
169. Olson MB, Kelsey SF, Bittner V, Reis SE, Reichek N, Handberg EM, Merz
CNB.
Weight cycling and high-density lipoprotein cholesterol in women: evidence of an
adverse effect.
J Am Coll Cardiol 2000; 36 (5): 1565-71.
170. Wexberg P, Gyöngyösi M, Sperker W, Kiss K, Yang P, Hassan A,
Pasterkamp G, Glogar D.
Pre-existing arterial remodeling is associated with in-hospital and late adverse
cardiac events after coronary interventions in patients with stable angina pectoris.
J Am Coll Cardiol 2000; 36 (6): 1860-9.
171. Finci L, Ferraro M, Nishida T, Albiero R, Corvaja N, Vaghetti M, Stankovic
G, Recchia M, Di Mario C, Colombo A.
Coronary stenting beyond standard indications. Immediate and follow-up results.
Ital Heart J 2000; 1 (11): 739-48.
_____________________________________________________________________
QCA-CMS-References
18
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
172. Melo WDS, Prudencio LAR, Kusnir CE, Pereira ALN, Marques V, Vieira
MC, de Paola AAV.
Anatomia Angiográfica do Sistema Venoso Coronário. Aplicações em
Eletrofisiologia Clínica.
Arq Bras Cardiol 1998; 70 (6): 409-413.
173. Giri S, Ito S, Lansky AJ, Mehran R, Margolis J, Gilmore P, Garratt KN,
Cummins F, Moses J, Rentrop P, Oesterle S, Power J, Kent KM, Satler LF,
Pichard AD, Wu H, Greenberg A, Bucher TA, Kerker W, Abizaid AS,
Saucedo J, Leon MB, Popma JJ.
Clinical and angiographic outcome in the laser angioplasty for restenotic stents
(LARS) Multicenter Registry.
Cath and Cardiovasc Interventions 2001; 52: 24-34.
174. Kastrati A, Koch W, Berger PB, Mehilli J, Stephenson K, Neumann FJ,
Beckerath N von, Böttiger C, Duff GW, Schömig A.
Protective role against restenosis from an interleukin-1 receptor antagonist gene
polymorphism in patients treated with coronary stenting.
J Am Coll Cardiol 2000; 36 (7): 2168-73.
175. Rodriguez A, Bernardi V, Navia J, Baldi J, Grinfeld L, Martinez J, Vogel D,
Grinfeld R, Delacasa A, Garrido M, Oliveri R, Mele E, Palacios I, O’Neill W.
Argentine randomized study: coronary angioplasty with stenting versus coronary
bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and
one-year follow-up results.
J Am Coll Cardiol 2001; 37 (1): 51-8.
176. Endo A, Hirayama H, Yoshida O, Arakawa T, Akima T, Yamada T,
Nanasato M.
Arterial remodeling influences the development of intimal hyperplasia after stent
implantation.
J Am Coll Cardiol 2001; 37 (1): 70-5.
177. Azevedo ER, Schofield AM, Kelly S, Parker JD.
Nitroglycerin withdrawal increases endothelium-dependent vasomotor response to
acetylcholine.
J Am Coll Cardiol 2001; 37 (2): 505-9.
178. Reiber JHC, Koning G, Tuinenburg JC, Goedhart B.
Quantitative Coronary Arteriography.
In: Interventional fluoroscopy. S Balter, editor. Wiley-Liss Publishers, New
York 2001: 131-147.
179. Heuser R, Lopez A, Kuntz R, Reduto L, Badger R, Coleman P, Whitlow P,
Iannone LA, Safian R, Yeung A, Moses J.
SMART: The MicroStent’s Ablility to Limit Restenosis Trial.
Cath and Cardiovasc Interventions 2001; 52: 269-277.
180. Walter DH, Fichtlscherer S, Sellwig M, BS, Auch-Schwelk W, Schächinger V,
Zeiher AM.
Preprocedural C-reactive protein levels and cardiovascular events after coronary
stent implantation.
J Am Coll Cardiol 2001; 37 (3): 839-46.
_____________________________________________________________________
QCA-CMS-References
19
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
181. Chauhan MS, Kuntz RE, Ho KKL, Cohen DJ, Popma JJ, Carrozza JP,
Baim DS, Cutlip DE.
Coronary artery stenting in the aged.
J Am Coll Cardiol 2001; 37 (3): 856-62.
182. Walter DH, Schächinger V, Elsner M, Mach S, Dimmeler S, Auch-Schwelk
W, Zeiher AM.
Statin therapy is associated with reduced restenosis rates after coronary stent
implantation in carriers of the PIA2 allele of the platelet glycoprotein IIIa gene.
Eur Heart J 2001; 22: 587-95.
183. Moreno R, Garcia E, Soriano J, Acosta J, Abeytua M.
Long-term outcome of patients with proximal left anterior descending coronary
artery In-Stent restenosis treated with rotational atherectomy
Cathet Cardiovasc Diagn 2001; 52: 435-42.
184. Meuwissen M, Piek JJ, Wal AC van der, Chamuleau SAJ, Koch KT, Teeling
P, Loos CM van der, Tijssen JGP, Becker AE.
Recurrent unstable angina after directional coronary atherectomy is related to the
extent of initial coronary plaque inflammation.
J Am Coll Cardiol 2001; 37 (5): 1271-6.
185. Chamuleau SAJ, Meuwissen M, Eck-Smit BLF van, Koch KT, Jong A de,
Winter RJ de, Schotborgh CE, Bax M, Verberne HJ, Tijssen JGP, Piek JJ.
Fractional flow reserve, absolute and relative coronary blood flow velocity reserve
in relation to the results of technetium-99m sestamibi single-photon emission
computed tomography in patients with two-vessel coronary artery disease.
J Am Coll Cardiol 2001; 37 (5): 1316-22.
186. Kop WJ, Krantz DS, Howell RH, Ferguson MA, Papademetriou V, Lu D,
Popma JJ, Quigley JF, Vernalis M, Gottdiener JS.
Effects of mental stress on coronary epicardial vasomotion and flow velocity in
coronary artery disease: relationship with hemodynamic stress responses.
J Am Coll Cardiol 2001; 37 (5): 1359-66.
187. Goldberg SL, Loussararian A, De Gregorio J, Di Mario C, Albiero R,
Colombo A.
Predictors of diffuse and aggressive Intra-Stent restenosis.
J Am Coll Cardiol 2001; 37 (4): 1019-25.
188. Kim HS, Waksman R, Cottin Y, Kollum M, Bhargava B, Mehran R, Chan
RC, Mintz GS.
Edge stenosis and geographical miss following intracoronary gamma radiation
therapy for In-Stent restenosis.
J Am Coll Cardiol 2001; 37 (4): 1026-30.
189. Baldus S, Köster R, Reimers J, Kähler J, Meinertz Th, Hamm CW.
Membrane-covered stents: A new treatment strategy for saphenous vein graft
lesions.
Cath and Cardiovasc Interventions 2001; 53: 1-4.
_____________________________________________________________________
QCA-CMS-References
20
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
190. Karvouni E, Di Mario C, Nishida T, Tzifos V, Reimers B, Albiero R,
Corvaja N, Colombo A.
Directional atherectomy prior to stenting in bifurcation lesions: A matched
comparison study with stenting alone.
Cath and Cardiovasc Interventions 2001; 53: 12-20.
191. Duffy SJ, Gelman JS, Peverill RE, Greentree MA, Harper RW, Meredith IT.
Agreement between coronary flow velocity reserve and stress echocardiography in
intermediate-severity coronary stenoses.
Cath and Cardiovasc Interventions 2001; 53: 29-38.
192. Galli M, Sommariva L, Prati F, Zerboni S, Politi A, Bonatti R, Mameli S,
Butti E, Pagano A, Ferrari G.
Acute and mid-term results of phosphorylcholine-coated stents in primary coronary
stenting for acute myocardial infarction.
Cath and Cardiovasc Interventions 2001; 53: 182-7.
193. Haegeli L, Quitzau K and Lüscher TF on behalf of the Steering Committee
and the Investigators of the ENCORE trials.
From endothelial dysfunction to clinical events. Concept and update on the
ENCORE trials.
Eur Heart J 2001; 3 (supplement B): B12-9.
194. Birgelen C von, Klinkhart W, Mintz GS, Papatheodorou A, Herrmann J,
Baumgart D, Haude M, Wieneke H, Ge J, Erbel R.
Plaque distribution and vascular remodeling of ruptured and nonruptured coronary
plaques in the same vessel: an intravascular ultrasound study in vivo.
J Am Coll Cardiol 2001; 37 (7): 1864-70.
195. Schühlen H, Kastrati A, Pache J, Dirschinger J, Schömig A.
Incidence of thrombotic occlusion and major adverse cardiac events between two
and four weeks after coronary stent placement: analysis of 5,678 patients with a
four-week ticlopidine regimen.
J Am Coll Cardiol 2001; 37 (8): 2066-73.
196. Reiber JHC , Koning G, Dijktra J, Wahle A, Goedhart B, Sheehan FH,
Sonka M.
Angiography and Intravascular Ultrasound.
In: Handbook of Medical Imaging, Vol.2: Medical Image Processing and
Analysis. M. Sonka, J. Michael Fitzpatrick (Eds.). SPIE, Belligham, WA, 2000:
711-808.
197. Hehrlein C, DeVries JJ, WoodTA, Haller SD, Arab A, Kloostra AC,
Lauer MA, Fischell TA.
Overestimation of stent delivery balloon diameters by manufacturers' compliance
tables: A quantitative coronary analysis of Duet and NIR stent implantation.
Cath and Cardiovasc Interventions 2001; 53: 474-8.
198. Adamian M, Colombo A, Briguori C, Nishida T, Marsico F, Di Mario C,
Albiero R, Moussa I, Moses JW.
Cutting balloon angioplasty for the treatment of in-stent restenosis: a matched
comparison with rotational atherectomy, additional stent implantation and balloon
angioplasty
J Am Coll Cardiol 2001; 38 (3): 672-9.
_____________________________________________________________________
QCA-CMS-References
21
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
199. Foley DP, Kererakes D, Riele JAM te, Nishimura N, Veldhof S, Fink S,
Yeung A, Hoogenhuyze D van, Lansky AM, Es GA van, Kutryk MJB,
Serruys PW.
Acute and 6-month clinical and angiographic outcome after implantation of the
ACS Duet stent for single-vessel coronary artery disease: final results of the
European and U.S. ACS Multi-Link Duet Registry.
Cath and Cardiovasc Interventions 2001; 54: 25-33.
200. Berg JM ten, Kelder JC, Suttorp MJ, Verheugt FWA, Plokker HWT.
Influence of planned six-month follow-up angiography on late outcome after
percutaneous coronary intervention.
J Am Coll Cardiol 2001; 38 (4): 1061-9.
201. Colombo A, De Gregorio J, Moussa I, Kobayashi Y, Karvouni E, Di Mario C,
Albiero R, Finci L, Moses J.
Intravascular ultrasound-guided percutaneous transluminal coronary angioplasty
with provisional spot stenting for treatment of long coronary lesions.
J Am Coll Cardiol 2001; 38 (5): 1427-33.
202. Jørgensen E, Kelbæk H, Helqvist S, Jensen GVH, Saunamäki K, Kastrup J,
Havndrup O, Bundgaard H, Madsen JK, Christiansen M, Andersen PS,
Reiber JHC.
Predictors of coronary in-stent restenosis: importance of angiotensin-converting
enzyme gene polymorphism and treatment with angiotensin-converting enzyme
inhibitors.
J Am Coll Cardiol 2001; 38 (5): 1434-9.
203. Ishii Y, Weert AWM, Hekking E, De Marie K, Horst J ter, Oemrawsingh PV,
Reiber JHC.
A novel quantitative method for evaluating diffuse in-stent narrowing at follow-up
angiography.
Cath and Cardiovasc Interventions 2001; 54: 309-17.
204. Moer R, Myreng Y, Mølstad P, Albertsson P, Gunnes P, Lindvall B, Wiseth R,
Ytre-Arne K, Kjekshus J, Golf S.
Stenting in small coronary arteries (SISCA) trial. A randomized comparison
between balloon angioplasty and the heparin-coated beStent
J Am Coll Cardiol 2001; 38 (6): 1598-603.
205. Mehilli J, Kastrati A, Dirschinger J, Dotzer F, Schühlen H, Fleckenstein M,
Neumann F-J, Schömig A.
A randomized trial comparing the hand-mounted JoStent with the premounted
Multi-Link duet stent in patients with coronary artery disease.
Cath and Cardiovasc Interventions 2001; 54: 414-9.
206. Antoniucci D, Valenti R, Migliorini A, Moschi G, Trapani M, Bolognese L,
Santoro GM, Cerisano G.
Clinical and angiographic outcomes following elective implantation of the
Carbostent in patients at high risk of restenosis and target vessel failure.
Cath and Cardiovasc Interventions 2001; 54: 420-6.
_____________________________________________________________________
QCA-CMS-References
22
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
207. Karvouni E, Stankovic G, Albiero R, Takagi T, Corvaja N, Vaghetti M, Di
Mario C, Colombo A.
Cutting balloon angioplasty for treatment of calcified coronary lesions.
Cath and Cardiovasc Interventions 2001; 54: 473-81.
208. Walter DH, Fichtlscherer S, Britten MB, Rosin P, Auch-Schwelk W,
Schächinger V, Zeiher AM.
Statin therapy, inflammation and recurrent coronary events in patients following
coronary stent implantation.
J Am Coll Cardiol 2001; 38 (7): 2006-12.
209. Coussement PK, Stella P, Vanbilloen H, Verbruggen A, Rijk P van,
Hoekstra A, Van Limbergen E, Jaegere P de, De Scheerder I.
Intracoronary beta-radiation of de novo coronary lesions using a 186Re liquid-filled
balloon system: Six-month results from a clinical feasibility study
Cath and Cardiovasc Interventions 2002; 55: 28-36.
210. Takahashi T, Honda Y, Russo RJ, Fitzgerald PJ.
Intravascular ultrasound and quantitative coronary angiography
Cath and Cardiovasc Interventions 2002; 55: 118-28.
211. Lansky AJ, Dangas G, Mehran R, Desai KJ, Mintz GS, Wu H, Fahy M,
Stone GW, Waksman R, Leon MB.
Quantitative angiographic methods for appropriate end-point analysis, edge-effect
evaluation, and prediction of recurrent restenosis after coronary brachytherapy with
gamma irradiation.
J Am Coll Cardiol 2002; 39 (2): 274-80.
212. Langerak SE, Vliegen HW, Roos A de, Zwinderman AH. Jukema JW, Kunz
P, Lamb HJ, Wall EE van der.
Detection of vein graft disease using high-resolution Magnetic Resonance
Angiography.
Circulation 2002; 105: 328-33.
213. Al-Bustami MH, Amrani M, Chester AH, Ilsley CJ, Yacoub MH.
In vivo early and mid-term flow-mediated endothelial function of the radial artery
used as a coronary bypass graft.
J Am Coll Cardiol 2002; 39 (4): 573-7.
214. Gruberg L, Weissman NJ, Waksman R, Fuchs S, Deible R, Pinnow EE,
Ahmed LM, Kent KM, Pichard AD, Suddath WO, Satler LF, Lindsay J. Jr.
The impact of obesity on the short-term and long-term outcomes after percutaneous
coronary intervention: the obesity paradox?
J Am Coll Cardiol 2002; 39 (4): 578-84.
215. Briguori C, Sarais C, Sivieri G, Takagi T, Di Mario C, Colombo A.
Polytetrafluoroethylene-covered stent and coronary artery aneurysms.
Cath and Cardiovasc Interventions 2002; 55: 326-30.
216. Voudris V, Athanassopoulos G, Vassilikos V, Avramides D, Manginas A,
Michalis A, Cokkinos DV.
Usefulness of flow reserve in the left internal mammary artery to determine graft
patency to the left anterior descending coronary artery.
Am J Cardiol. 1999; 83: 1157-63.
_____________________________________________________________________
QCA-CMS-References
23
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
217. Chamuleau SAJ, Tio RA, Cock CC de, Muinck ED de, Pijls NHJ, Eck-Smit
BLF van, Koch KT, Meuwissen M, Dijkgraaf MGW, Jong A de, Verberne HJ,
Liebergen RAM van, Laarman GJ, Tijssen JGP, Piek JJ.
Prognostic value of coronary blood flow velocity and myocardial perfusion in
intermediate coronary narrowings and multivessel disease.
J Am Coll Cardiol 2002; 39 (5): 852-8.
218. Ibrahim T, Nekolla SG, Schreiber K, Odaka K, Volz S, Mehilli J, Güthlin M,
Delius W, Schwaiger M.
Assessment of coronary flow reserve: comparison between contrast-enhanced
magnetic resonance imaging and positron emission tomography.
J Am Coll Cardiol 2002; 39 (5): 864-70.
219. Brosh D, Higano ST, Slepian MJ, Miller HI, Kern MJ, Lennon RJ, Holmes
DR, Lerman A.
Pulse transmission coefficient: a novel nonhyperemic parameter for assessing the
physiological significance of coronary artery stenoses.
J Am Coll Cardiol 2002; 39 (6): 1012-9.
220. Briguori C, Tobis J, Nishida T, Vaghetti M, Albiero R, Di Mario C,
Colombo A.
Discrepancy between angiography and intravascular utrasound when analysing
small coronary arteries.
Eur Heart J 2002; 23: 247-54.
221. Nishida T, Di Mario C, Kern MJ, Anderson TJ, Moussa I, Bonan R,
Muramatsu T, Jain AC, Suarez de Lezo J, Cho SY, Meredith IT, Moses JW,
Colombo A.
Impact of final coronary flow velocity reserve on late outcome following stent
implantation.
Eur Heart J 2002; 23: 331-40.
222. Pache J, Kastrati A, Mehilli J, Gawaz M, Neumann F-J, Seyfarth M, Hall D,
Braun S, Dirschinger J, Schömig A.
Clopidogrel therapy in patients undergoing coronary stenting: value of a highloading-dose regimen.
Cath and Cardiovasc Interventions 2002; 55(4): 436-41.
223. Sheynberg BV, Jang I-K, Han RO, Sabatine MS, Brown DFM, Dinsmore R.
Comparison of two different methods of quantitative coronary angiography in
patients with acute coronary syndromes.
Cath and Cardiovasc Interventions 2002; 55(4): 442-9.
224. Fernández-Avilés F, Alonso JJ, Gimeno F, Ramos B, Durán JM, Bermejo J,
de la Fuente L, Muñoz JC, Garcimartín, García-Morán E, Sanz O, Serrador
A, San Román JA.
Safety of coronary stenting early after thrombolysis in patients with acute
myocardial infarction: one- and six-month clinical and angiographic evolution.
Cath and Cardiovasc Interventions 2002; 55(4): 467-76.
225. Ajani AE, Waksman R, Cha D-H, Gruberg L, Satler LF, Pichard AD,
Kent KM.
The impact of lesion length and reference vessel diameter on angiographic
restenosis and target vessel revascularization in treating in-stent restenosis with
_____________________________________________________________________
QCA-CMS-References
24
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
radiation.
J Am Coll Cardiol 2002; 39(8): 1290-6.
226. Martínez-Elbal L, Ruiz-Nodar JM, Zueco J, López-Minguez JR, Moreu J,
Calvo I, Ramirez JA, Alonso M, Vazquez N, Lezaun R, Rodriguez C for the
DISCO Investigators.
Direct coronary stenting versus stenting with balloon pre-dilation: immediate
and follow-up results of a multicentre, prospective, randomized study. The
DISCO trial.
Eur Heart J 2002; 23: 633-40.
227. Liistro F, Stankovic G, Di Mario C, Takagi T, Chieffo A, Moshiri S,
Montorfano M, Carlino M, Briguori C, Pagnotta P, Albiero R, Corvaja N,
Colombo A.
First clinical experience with a paclitaxel derivate-eluting polymer stent system
implantation for In-Stent restenosis; immediate and long-term clinical angiographic
outcome.
Circulation 2002; 105: 1883-6.
228. Berg JM ten, Kelder JC, Suttorp MJ, Mast EG, Bal ET, Ernst JMPG,
Plokker HWM.
Early and late effects of coumarin therapy started before percutaneous coronary
intervention; clinical, angiographic and cost-effective outcoume of the Balloon
Angioplasty and Anticoagulation Study (BAAS).
Neth Heart J 2002; 10: 235-40.
229. Yu Z-X, Tamai H, Kyo E, Kosuga K, Hata T, Okada M, Nakamura T,
Komori H, Tsuji T, Takeda S, Motohara S, Uehata H.
Comparison of the self-expanding radius stent and the balloon-expandable
multilink stent for elective treatment of coronary stenoses: a serial analysis by
intravascular ultrasound.
Cath and Cardiovasc Interventions 2002; 56(1): 40-5.
230. Gruberg L, Waksman R, Ajani AE, Kim H-S, White RL, Pinnow EE,
Satler LF, Pichard AD, Kent KM, Lindsay J Jr.
The effect of intracoronary radiation for the treatment of recurrent In-Stent
restenosis in patiensts with diabetes mellitus.
J Am Coll Cardiol 2002; 39 (12): 1930-6.
231. Maehara A, Patel NS, Harrison LB, Weissman NJ, Bui AB, Kim H-S, Ajani
AE, Castagna MT, McMillan TL, Yang N, Chan R, Pisch J, Quan H, ChiuTsao S-T, Waksman R, Mintz GS.
Dose heterogeneity may not affect the neointimal proliferation after gamma
radiation for in-stent restenosis.
J Am Coll Cardiol 2002; 39 (12): 1937-42.
232. Tuinenburg JC, Koning G, Hekking E, Desjardins C, Harel F, Bilodeau L,
Weert AWM van, Lespérance J, Reiber JHC.
One core laboratory at two international sites, is that feasible? An inter-core
_____________________________________________________________________
QCA-CMS-References
25
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
laboratory and intra-observer variability study.
Cath and Cardiovasc Interventions 2002; 56(3): 333-40.
233. Gercken U, Lansky AJ, Buellesfeld L, Desai K, Badereldin M, Mueller R,
Selbach G, Leon MB, Grube E.
Results of the Jostent coronary stent graft implantation in various clinical
settings: procedural and follow-up results.
Cath and Cardiovasc Interventions 2002; 56(3): 353-60.
234. Takagi T, Di Mario C, Stankovic G, Reimers B, Alberti A, Liistro F,
Kovalenko O, Sgura F, Albiero R, Ribichini F, Pugno A, Colombo A.
Effective plaque removal with a new 8 French-compatible atherectomy catheter.
Cath and Cardiovasc Interventions 2002; 56(4): 452-9.
235. Briguori C, Sarais C, Pagnotta P, Liistro F, Montorfano M, Chieffo A,
Sgura F, Corvaja N, Albiero R, Stankovic G, Toutoutzas C, Bonizzoni E, Di
Mario C, and Colombo A.
In-stent restenosis in small coronary arteries: impact of strut thickness.
J Am Coll Cardiol 2002; 40(3): 403-9.
236. Hausleiter J, Kastrati A, Mehilli J, Schühlen H, Pache J, Dotzer F,
Dirschinger J, and Schömig A.
Predictive factors for early cardiac events and angiographic restenosis after
coronary stent placement in small coronary arteries.
J Am Coll Cardiol 2002; 40(5): 882-9.
237. Hanratty CG, Koyama Y, Rasmussen HH, Nelson GIC, Hansen PS, Ward
MR.
Exaggeration of nonculprit stenosis severity during acute myocardial infarction:
implications for immediate multivessel revascularization.
J Am Coll Cardiol 2002; 40(5): 911-6.
238. Popma JJ, Cox N, Hauptmann KE, Reifart N, Virmani R, Emira K,
Murphy S, Gibson CM, Grube E.
Initial clinical experience with distal protection using the FilterWire in patients
undergoing coronary artery and saphenous vein graft percutaneous intervention.
Cath and Cardiovasc Interventions 2002; 57(2): 125-34.
239. Prati F, Pawlowski T, Sommariva L, Labellarte A, Manzoli A, Boccanelli A,
Motolese M.
Intravascular ultrasound and quantitative coronary angiography assessment of
late in-stent restenosis: In vivo human correlation and methodological
implications.
Cath and Cardiovasc Interventions 2002; 57(2): 155-60.
240. Waksman R, Buchbinder M, Reisman M, Lansky AJ, Trauthen B,
Whiting J, Li A.
_____________________________________________________________________
QCA-CMS-References
26
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
Balloon-based radiation therapy for treatment of in-stent restenosis in human
coronary arteries: results from the BRITE I study.
Cath and Cardiovasc Interventions 2002; 57(3): 286-94.
241. Yamamoto K, Ito H, Iwakura K, Kawano S, Ikushima M, Masuyama T,
Ogihara T, Fujii K.
Two different coronary blood flow velocity patterns in thrombolysis in
myocardial infarction flow grade 2 in acute myocardial infarction. Insight into
mechanisms of microvascular dysfunction.
J Am Coll Cardiol 2002; 40(10): 1755-60.
242. Boschat J, Le Breton H, Commeau P, Huret B, Bedossa M, Gelard M.
Is coronary stent deployment and remodeling affected by predilatation? An
intravascular ultrasound randomized study.
Int J Cardiac Imaging 2002; 18(6): 399-404.
243. Gomma AH, Elrayess MA, Knight CJ, Hawe E, Fox KM, Humphries SE.
The endothelial nitric oxide synthase (Glu298Asp and -786T>C) gene
polymorphisms are associated with coronary in-stent restenosis.
Eur Heart J 2002; 23(24): 1955-62.
244. Tamita K, Akasaka T, Takagi T, Yamamuro A, Yamabe K, Katayama M,
Morioka S, Yoshida K.
Effects of microvascular dysfunction on myocardial fractional flow reserve after
percutaneous coronary intervention in patients with acute myocardial infarction.
Cath and Cardiovasc Interventions 2002; 57(4): 452-9.
245. Versaci F, Gaspardone A, Tomai F, Ribichini F, Russo P, Proietti I, Ghini
AS, Ferrero V, Chiariello L, Gioffrè PA, Romeo F, Crea F.
Immunosuppressive therapy for the prevention of restenosis after coronary artery
stent implantation (IMPRESS study).
J Am Coll Cardiol 2002; 40(11): 1935-42.
246. Kini AS, Lee P, Mitre CA, Duffy ME, Sharma SK.
Postprocedure chest pain after coronary stenting: implications on clinical
restenosis.
J Am Coll Cardiol 2003; 41(1): 33-8.
247. Silva JA, White CJ, Ramee SR, Collins TJ, Jenkins JS, Ho K, Baim DS,
Carrozza JP, Rinfret S, Setum CM, Popma JJ, Kuntz RE.
Treatment of coronary stent thrombosis with rheolytic thrombectomy: Results
from a multicenter experience.
Cath and Cardiovasc Interventions 2003; 58(1): 11-7.
248. Toutouzas K, Stankovic G, Takagi T, Albiero R, Corvaja N, Milici C, Di
Mario C, Finci L, Colombo A.
_____________________________________________________________________
QCA-CMS-References
27
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
A new dedicated stent and delivery system for the treatment of bifurcation
lesions: Preliminary experience.
Cath and Cardiovasc Interventions 2003; 58(1): 34-42.
249. Sanchez PL, Rodriguez-Alemparte M, Colon-Hernandez PJ, Pomerantsev
E, Inglessis I, Mahdi NA, Leinbach RC, Palacios IF.
Directional coronary atherectomy vs. rotational atherectomy for the treatment of
In-Stent restenosis of native coronary arteries.
Cath and Cardiovasc Interventions 2003; 58(2): 155-61.
250. Ajani AE, Waksman R, Cheneau E, Cha DH, McGlynn S, Castagna M,
Chan RC, Satler LF, Kent KM, Pichard AD, Pinnow E, Lindsay J.
The outcome of percutaneous coronary intervention in patients with in-stent
restenosis who failed intracoronary radiation therapy.
J Am Coll Cardiol 2003; 41(4): 551-6.
251. Ashby DT, Dangas G, Aymong EA, Iakovou I, Kuepper F, Mehran R,
Stone GW, Leon MB, Moses JW.
Effect of percutaneous coronary interventions for in-stent restenosis in
degenerated saphenous vein grafts without distal embolic protection.
J Am Coll Cardiol 2003; 41(5): 749-52.
252. Leesar MA, Abdul-Baki T, Akkus NI, Sharma A, Kannan T, Bolli R.
Use of fractional flow reserve versus stress perfusion scintigraphy after unstable
angina. Effect on duration of hospitalization, cost, procedural characteristics,
and clinical outcome.
J Am Coll Cardiol 2003; 41(7): 1115-21.
253. Olivari Z, Rubartelli P, Piscione F, Ettori F, Fontanelli A, Salemme L,
Giachero C, Di Mario C, Gabrielli G, Spedicato L, Bedogni F.
Immediate results and one-year clinical outcome after percutaneous coronary
interventions in chronic total occlusions: data from a multicenter, prospective,
observational study (TOAST-GISE).
J Am Coll Cardiol 2003; 41(10): 1672-8.
254. Costantini CO, Lansky AJ, Mintz GS, Shirai K, Dangas G, Mehran R,
Fahy M, Slack S, Coral M, Teirstein PS, Waksman R, Stone G, Moses J,
Leon MB.
Intravascular brachytherapy for native coronary ostial in-stent restenotic lesions.
J Am Coll Cardiol 2003; 41(10): 1725-31.
255. Cha D-H, Malik IA, Cheneau E, Ajani AE, Leborgne L, Wolfram R,
Porrazzo M, Satler LF, Kent KM, Pichard AD, Pinnow E, Lindsay J,
Waksman R.
Use of restenting should be minimized with intracoronary radiation therapy for
in-stent restenosis.
Cath and Cardiovasc Interventions 2003; 59(1): 1-5.
_____________________________________________________________________
QCA-CMS-References
28
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
256. Ruygrok PN, Webster MW, Ardill JJ, Chan CC, Mak KH, Meredith IT,
Stewart JT, Ormiston JA, Price S.
Vessel caliber and restenosis: A prospective clinical and angiographic study of
NIR stent deployment in small and large coronary arteries in the same patient.
Cath and Cardiovasc Interventions 2003; 59(2): 165-71.
257. Escaned J, Cortés J, Flores A, Goicolea J, Alfonso F, Hernández R,
Fernández-Ortiz A, Sabaté M, Bañuelos C, Macaya C.
Importance of diastolic fractional flow reserve and obutamine challenge in
physiologic assessment of myocardial bridging.
J Am Coll Cardiol 2003; 42(2): 226-33.
258. Caputo RP, Flately M, Ho KKL, Baim DS.
Safety and effectiveness of stent implantation without predilation for small
coronary arteries.
Cath and Cardiovasc Interventions 2003; 59(4): 455-8.
259. Olson MB, Kelsey SF, Matthews K, Shaw LJ, Sharaf BL, Pohost GM,
Cornell CE, McGorray SP, Vido D, Merz CNB.
Symptoms, myocardial ischaemia and quality of life in women: Results from the
NHLBI-sponsored WISE Study.
Eur Heart J 2003; 24 (16): 1506-14.
260. Mehilli J, Kastrati A, Bollwein H, Dibra A, Schühlen H, Dirschinger J,
Schömig A.
Gender and restenosis after coronary artery stenting.
Eur Heart J 2003; 24 (16): 1523-30.
261. Kelley MP, Klugherz BD, Hashemi SM, Meneveau NF, Johnston JM,
Matthai Jr WH, Banka VS, Herrmann HC, Hirshfeld Jr JW, Kimmel SE,
Kolansky DM, Horwitz PA, Schiele F, Bassand J-P L, Wilensky RL.
One-year clinical outcomes of protected and unprotected left main coronary
artery stenting.
Eur Heart J 2003; 24 (17): 1554-9.
262. Alfonso F, Zueco J, Cequier A, Mantilla R, Bethencourt A, López-Minguez
JRAngel J, Augé JM, Gómez-Recio, Moris C, Seabra-Gomes R, PerezVizcayno MJ, Macaya C, for the Restenosis Intra-stent: Balloon
angioplasty Versus Elective Stenting (RIBS) Investigatitors.
A randomized comparison of repeat stenting with balloon angioplasty in patients
with in-stent restenosis.
J Am Coll Cardiol 2003; 42(5): 796-805.
263. Staal EM, Heer M de, Jukema JW, Koning G, Wall EE van der, Reiber
JHC, Baan J, Steendijk P.
End-diastolic and end-systolic volume from the left ventricular angiogram: how
accurate is visual frame selection?
_____________________________________________________________________
QCA-CMS-References
29
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
Int J Cardiac Imaging 2003; 19: 259-66.
264. Grube E, Silber S, Hauptmann KE, Mueller R, Buellesfeld L, Gerckens U,
Russell ME.
Six- and twelve-month results from a randomized, double-blind trial on a slowrelease paclitaxel-eluting stent for de novo coronary lesions.
Circulation 2003; 107: 38-42.
265. Orlic D, Reimers B, Stankovic G, Corvaja N, Chieffo A, Airoldi F, Spanos
V, Favero L, Di Mario C, Antonio C.
Initial experience with a new 8 French-Compatible directional atherectomy
catheter: Immediate and mid-term results.
Cath and Cardiovasc Interventions 2003; 60(2): 159-66.
266. Oemrawsingh PV, Tuinenburg, JC, Schalij MJ, Jukema JW, Reiber JHC,
Bruschke AVG.
Clinical and angiographic outcome of micro stent II implantation in native
coronary arteries.
Am J of Cardiol 1998; 81(2): 152-7.
267. Schalij MJ, Udayachalerm W, Oemrawsingh P, Jukema JW, Reiber JHC,
Bruschke AVG.
Stenting of long coronary artery lesions: initial angiographic results and 6
months clinical outcome of the micro stent II-XL.
Cathet Cardiovasc Intervent 1999; 48: 105-12.
268. Oemrawsingh PV, Schalij MJ, Srimahachota S, Jukema JW, Bruschke
AVG.
Clinical and angiographic outcome of stent implantation without predilatation
using the Jostent flex stent.
J Invasive Cardiol 1998; 12(4): 187-93.
269. Oemrawsingh PV, Dijkstra J, Koning G, Heijer P den, Schalij MJ.
Cutting balloon predilation to optimize stent expansion: the cutting balloon used
before stent (COBUS) study.
Submitted
270. Oemrawsingh PV, Mintz GS, Schalij MJ, Jukema JW, Wall EE van der.
Intravascular ultrasound guidance improves angiographic and clinical outcome
of stent implantation for long coronary artery stenosis: final results of a
randomized comparison with angiographic guidance.
Circulation 2003; 107(1): 62-7.
271. Schächinger V, Hamm CW, Münzel T, Haude M, Baldus S, Grube E,
Bonzel T, Konorza T, Köster R, Arnold R, Haase J, Probst P, Dahl J vom,
Neumann F-J, Mudra H, Hennen B, Thiele L, Zeiher AM for the STING
Investigators.
A randomized trial of polytetrafluoroethylene-membrane-covered stents
compared with conventional stents in aortocoronary saphenous vein grafts.
_____________________________________________________________________
QCA-CMS-References
30
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
J Am Coll Cardiol 2003; 42(8): 1360-9.
272. Sharaf BL, Pepine CJ, Kerensky RA, Reis SE, Reichek N, Rogers WJ,
Sopko G, Kelsey SF, Holubkov R, Olson M, Miele NJ, Williams DO, Bairey
Merz CN, for the WISE Study Group.
Detailed angiographic analysis of women with suspected ischemic chest pain
(pilot phase data from the NHLBI-Sponsored women’s ischemia syndrome
evaluation (WISE) study angiographic core laboratory).
Am J Cardiol 2001; 87: 937-41.
273. Wijpkema JS, Jessurun GAJ, Boven AJ van, Versteeg DIK, Hautvast
RWM, Tio RA.
Clinical impact of Abciximab on long-term outcome after complex coronary
angioplasty.
Cathet Cardiovasc Intervent 2003; 60: 339-43.
274. Shah PB, Cutlip DE, Popma JJ, Kuntz RE, Ho KKL.
Incidence and predictors of late total occlusion following coronary stenting.
Cathet Cardiovasc Intervent 2003; 60: 344-51.
275. Chung C-M, Nakamura S, Tanaka K, Tanigawa J, Kitano K, Akiyama T,
Matoba Y, Katoh O.
Effect of recanalization of chronic total occlusions on global and regional left
ventricular function in patients with or without previous myocardial infarction.
Cathet Cardiovasc Intervent 2003; 60: 368-74.
276. Hamm CW, Hugenholtz PG, for the Trust Investigators.
Silicon carbide-coated stents in patients with acute coronary syndrome.
Cathet Cardiovasc Intervent 2003; 60: 375-81.
277. Sakai S, Mizuno K, Yokoyama S, Tanabe J, Shinada T, Seimiya K, Takano
M, Ohba T, Tomimura M, Uemura R, Imaizumi T.
Morphologic changes in infarct-related plaque after coronary stent placement.
J Am Coll Cardiol 2003; 42(9): 1558-65.
278. Moer R, Weert AWM van, Myreng Y & Mølstad P.
Variability of quantitative coronary angiography: an evaluation of on-site versus
core laboratory analysis.
Int J Cardiac Imaging 2003; 19: 457-64.
279. Huang Z, Katoh O, Nakamura S, Negoro S, Kobayashi T, Tanigawa J.
Evaluation of the Percusurge guardwire plus temporary occlusion and aspiration
system during primary angioplasty in acute myocardial infarction.
Cathet Cardiovasc Intervent 2003; 60: 443-51.
280. Hanekamp CEE, Koolen JJ, Heijer P den, Schalij MJ, Piek JJ, Bär
FWHM, Scheerder I de, Bonnier HJRM, Pijls NHJ for the Venestent Study
Group.
Randomized study to compare balloon angioplasty and elective stent
_____________________________________________________________________
QCA-CMS-References
31
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
implantation in venous bypass grafts: the Venestent Study.
Cathet Cardiovasc Intervent 2003; 60: 452-7.
281. Degertekin M, Lemos PA, Lee CH, Tanabe K, Sousa JE, Abizaid A, Regar
E, Sianos G, Giessen WJ van der, Feyter PJ de, Wuelfert E, Popma JJ,
Serruys PW.
Intravascular ultrasound evaluation after sirolimus eluting stent implantation for
de novo and in-stent restenosis lesions.
Eur Heart J 2004; 25 (1): 32-8.
282. Chen Y-H, Chau L-Y, Lin M-W, Chen L-C, Yo M-H, Chen J-W, Lin S-J.
Heme oxygenase-1 gene promotor microsatellite polymorphism is associated
with angiographic restenosis after coronary stenting.
Eur Heart J 2004; 25 (1): 39-47.
283. Kawamura A, Asakura Y, Okabe T, Yamane A, Hui-Chong L, Ogawa S.
Predictors of vessel remodeling following directional coronary atherectomy.
Cathet Cardiovasc Intervent 2004; 61: 44-51.
284. Brosh D, Higano ST, Kern MJ, Lennon RY, Holman DR Jr, Lerman A.
Pulse transmission coefficient: A nonhyperemic index for physiologic
assessment of procedural success following percutaneous coronary
interventions.
Cathet Cardiovasc Intervent 2004; 61: 95-102.
285. Fukuda D, Shimada K, Tanaka A, Kawarabayashi T, Yoshiyama M,
Yoshikawa J.
Circulation monocytes and in-stent neointima after coronary stent implantation.
J Am Coll Cardiol 2004;43(1): 18-23.
286. Mehilli J, Kastrati A, Dirschinger J, Etzel L, Bollwein H, Pache J, Schühlen
H, Beckerath N von, Seyfarth M, Schmitt C, Schömig A.
Intracoronary stenting and angiographic results: restenosis after direct stenting
versus stenting with predilation in patients with symptomatic coronary artery
disease (ISAR-DIRECT Trial).
Cathet Cardiovasc Intervent 2004; 61: 190-5.
287. Hoppmann P, Koch W, Schömig A, Kastrati A.
The 5A/6A polymorphsim of the stromelysin-1 gene and restenosis after
percutaneous coronary interventions.
Eur Heart J 2004; 25 (4): 335-41.
288. Kastrati A, Mehilli J, Nekolla S, Bollwein H, Martinoff S, Pache J,
Schühlen H, Seyfarth M, Gawaz M, Neumann F-J, Dirschinger J,
Schwaiger M, Schömig A, for the STOPAMI-3 Study Investigators
A randomized trial comparing myocardial salvage achieved by coronary stenting
versus balloon angioplasty in patients with acute myocardial infarction
considered ineligible for reperfusion therapy.
_____________________________________________________________________
QCA-CMS-References
32
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
J Am Coll Cardiol 2004; 43(5): 734-41.
289. Mehran R, Iakovou I, Dangas G, Lansky AJ, Stone GW, Mintz GS, Kent
KM, Pichard AD, Satler LF, Fahy M, Leon MB and Waksman R.
Gamma radiation for in-stent restenosis: effect of lesion length on angiographic
and clinical outcomes.
Cathet Cardiovasc Intervent 2004; 61: 354-9.
290. Chen W-H, Lee P-Y, Ng W, Lau C-P.
Safety and feasibility of the use of a distal filter protection device in
percutaneous revascularization of small coronary arteries.
Cathet Cardiovasc Intervent 2004; 61: 360-3.
291. Albiero R, Silber S, Di Mario C, Cernigliaro C, Battaglia S, Reibers B,
Frasheri A, Klauss V, Auge JM, Rubartelli P, Morice M-C, Cremonesi A,
Schofer J, Bortone A, Colombo A for the RESCUT Invetigators.
Cutting balloon versus conventional balloon angioplasty for the treatment of instent restenosis. Results of the restenosis cutting balloon evaluation trial
(RESCUT).
J Am Coll Cardiol 2004; 43(6): 943-9.
292. Tamai H, Berger PB, Tsuchikane E, Suzuki T, Nishikawa H, Aizawa T,
Fujii K, Nozaki Y, Kyo E, Kobayashi T, Reiber JHC, Weert AWM for the
MAJIC Investigators.
Frequency and time course of reocclusion and restenosis in coronary artery
occlusions after balloon angioplasty versus Wiktor stent implantation: results
from the Mayo-Japan Investigation for chronic total occlusion (MAJIC) trial.
Am Heart J 2004; 147: T1-T7.
293. Orlic D, Bonizzoni E, Stankovic G, Airoldi F, Chieffo A, Corvaja N,
Sangiorgi G, Ferraro M, Briguori C, Montorfano M, Carlino M, Colombo
A.
Treatment of multivessel coronary artery disease with sirolimus-eluting stent
implantation: immediate and mid-term results.
J Am Coll Cardiol 2004; 43(7): 1154-60.
294. Halkin A, Grines CL, Cox DA, Garcia E, Mehran R, Tcheng JE, Griffin JJ,
Guagliumi G, Brodie B, Turco M, Rutherford BD, Aymong E, Lansky AJ,
Stone GW.
Impact of intravenous beta-blockade before primary angioplasty on survival in
patients undergoing mechanical reperfusion therapy for acute myocardial
infarction.
J Am Coll Cardiol 2004; 43(10): 1780-7.
295. Bilodeau L, Fretz EB, Taeymans Y, Koolen J, Taylor K, Hilton DJ.
Novel use of a high-energy excimer laser catheter for calcified and complex
coronary artery lesions.
Cathet Cardiovasc Intervent 2004; 62: 155-61.
_____________________________________________________________________
QCA-CMS-References
33
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
296. Sagev A, Kassam S, Buller CE, Lau HK, Sparkes JD, Connelly PW,
Seidelin PH, Natarajan MK, Cohen EA, Strauss BH.
Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not
predict late coronary angiographic restenosis after elective stenting.
Eur Heart J 2004; 25 (12): 1029-35.
297. Siebes M, Verhoeff B-J, Meuwissen M, Winter RJ de, Spaan JAE, Piek JJ.
Single-wire pressure and flow velocity measurement to quantify coronary
stenosis hemodynamics and effects of percutaneous interventions.
Circulation 2004; 109: 756-62.
298. Reiber JHC, Koning G, Tuinenburg JC, Lansky A, Goedhart B.
Quantitative coronary arteriography.
In: Coronary Radiology. M. Oudkerk (Ed.) Springer-Verlag, Berlin 2004: 4158.
299. Iakovou I, Mehran R, Dangas G, Lansky AJ, Stone GW, Mintz GS,
Aymong E, Ashby DT, Pichard AD, Satler LF, Kent K, Leon MB,
Waksman R.
Favorable effect of γ-radiation for in-stent restenosis: effect of diabetes on
angiographic and clinical outcomes.
Cathet Cardiovasc Intervent 2004; 62: 303-7.
300. Gyöngyösi M, Khorsand A, Sperker W, Strehblow C, Wexberg P, Probst P,
Siostrzonek P, Lang I, Sochor H, Glogar D, Palmaz-Schatz, AVE, Amulet I,
Amulet II and Carbo Stent Registry Groups.
Short- and long-term clinical outcome after various stent implantation: overview
of the results of uni- and multicenter stent registries.
Cathet Cardiovasc Intervent 2004; 62: 331-8.
301. Sabaté M, Pimentel G, Prieto C, Corral JM, Bañuelos C, Angiolillo DJ,
Alfonso F, Hernández-Antolín, Escaned J, Fantidis P, Fernández C,
Fernández-Ortiz A, Moreno Raúl, Macaya C.
Intracoronary brachytherapy after stenting de novo lesions in diabetic patients.
Results of a randomized intravascular ultrasound study.
J Am Coll Cardiol, 2004; 44 (3): 520-7.
302. Chan C, Lim Y-L, Santoso T, Tresukosol D, Lim Y-T, Sonoda S, Fitzgerald
P.
Acute and long-term clinical and angiographic outcome after S-stent
implantation: S-stent multicenter safety and efficacy trial.
Cathet Cardiovasc Intervent 2004; 62 (4): 439-44.
303. Janssen JP, Koning G, Koning PJH de, Tuinenburg JC, Reiber JHC.
Validation of a new method for the detection of pathlines in vascular X-ray images.
Investigative Radiology 2004; 39 (9): 524-30.
_____________________________________________________________________
QCA-CMS-References
34
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
304. Iakovou I, Ge L, Michev I, Sangiorgi GM, Montorfano M, Airoldi F,
Chieffo A, Stankovic G, Vitrella G, Carlino M, Corvaja N, Briguori C,
Colombo A.
Clinical and angiographic outcome after sirolimus-eluting stent implantation in
aorto-ostial lesions.
J Am Coll Cardiol, 2004; 44(5): 967-71.
305. Tsuchikane E, Takeda Y, Nasu K, Awata N, Kobayashi T.
Balloon angioplasty plus cilostazol administration versus primary stenting of
small coronary artery disease: final results of COMPASS.
Cathet Cardiovasc Intervent 2004;63 (1): 44-51.
306. Briguori C, Colombo A, Airoldi F, Violante A, Focaccio A, Balestrieri P,
Elia PP, Golia B, Lepore S, Riviezzo G, Scarpato P, Librera M, Bonizzoni
E, Ricciardelli B.
Statin administration before percutaneous coronary intervention: impact on
periprocedural myocardial infarction.
Eur Heart J 2004; 25 (20): 1822-8.
307. Alfonso F, Melgares R, Mainar V, Lezaún R, Vàsquez N, Tascon J, Pomar
F, Cequier A, Angel J, Pérez-Vizcayno M-J, Sabaté M, Banuelos C,
Fernandez C, Garcia JM, for the restenosis intra-stent: balloon angioplasty
versus elective stenting (RIBS), Investigators.
Therapeutic implications of in-stent restenosis located at the stent edge. Insights
from the Restenosis Intra-stent Balloon angioplasty versus elective Stenting
(RIBS). Randomized trial.
Eur Heart J 2004; 25 (20): 1829-35.
308. Nakagawa T, Kobayashi T, Awata N, Sato S, Reiber JHC, Nakajima H,
Toyama YN, Hiraoka H, Kato O, Kirino M, Kobayashi T, Takeda Y,
Yachiku K, Iida M, Itoh T, Shibata N.
Randomized, controlled trial of secondary prevention of coronary sclerosis in
normocholesterolemic patients using pravastatin: final 5-year angiographic
follow-up of the prevention of coronary sclerosis (PCS) study.
Int J Cardiology 2004; (97): 107-14.
309. Waksman R, Ajani AE, Pichard AD, Torguson R, Pinnow E, Canos D,
Satler LF, Kent KM, Kuchulakanti P, Pappas C, Gambone L, Weissman N,
Abbott MC, Lindsay J.
Oral Rapamycin to inhibit restenosis after stenting of de novo coronary lesions.
J Am Coll Cardiol, 2004; 44(7): 1386-92.
310. Sahara M, Kirigaya H, Oikawa Y, Yajima J, Nagashima K, Hara H,
Ogasawara K, Aizawa T.
Soft plaque detected on intravascular ultrasound is the strongest predictor of instent restenosis: an intravascular ultrasound study.
Eur Heart J 2004; 25 (22): 2026-33.
_____________________________________________________________________
QCA-CMS-References
35
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
311. Barbato E, Bartunek J, Aarnoudse W, Vanderheyden M, Staelens F, Wijns
W, Heyndrickx GR, Pijls NHJ, Bruyne Bde.
Alpha-adrenergic receptor blockade and hyperaemic response in patients with
intermediate coronary stenoses.
Eur Heart J 2004; 25 (22): 2034-9.
312. Schömig A, Ndrepepa G, Mehilli J, Dirschinger J, Nekolla SG, Schmitt C,
Martinoff S, Seyfarth M, Schwaiger M, Kastrati A, for the STOPAMI-4
Study Investigators.
A randomized trial of coronary stenting versus balloon angioplasty as a rescue
intervention after failed thrombolysis in patients with acute myocardial
infarction.
J Am Coll Cardiol 2004; 44(10): 2073-9.
313. Sketch MH, Ball M, Rutherford B, Popma JJ, Russell C, Kereiakes DJ on
behalf of the Driver Investigators.
Evaluation of the Medtronic (driver) cobalt-chromium alloy coronary stent
system.
Am J Cardiol 2005; 95: 8-12.
314. Fassa A-A, Wagatsuma K, Higano ST, Mathew V, Barsness GW, Lennon
RJ, Holmes DR, Lerman A.
Intravascular ultrasound-guided treatment for angiographically indeterminate left
main coronary artery disease. A long-term follow-up study.
JACC 2005; 45: 204-11.
315. Iakovou I, Stankovic G, Montorfano M, Airoldi F, Chieffo A, Sangiorgi
GM, Carlino M, Corvaja N, Iassen M, Rogacka R, Vitrella G, Colombo A.
Is overdilatation of 3.0 mm sirolimus-eluting stent associated with a highter
restenosis rate?
Cathet Cardiovasc Intervent 2005;64 (1): 129-33.
316. Dirksen MS, Jukema JW, Bax JJ, Lamb HJ, Boersma E, Tuinenburg JC,
Geleijns J, Wall EE van der, Roos A de.
Cardiac multidetector-row computed tomography in patients with unstable
angina.
Am J Cardiol 2005;95: 457-61.
317. Chieffo A, Stankovic G, Bonizzoni E, Tsagalou E, Iakovou I, Montorfano
M, Airoldi F, Michev I, Sangiorgi MG, Carlino M, Vitrella G, Colombo A.
Early and mid-term results of drug-eluting stent implantation in unprotected left
main.
Circulation 2005;111: 791-5.
318. Rittersma SZH, Kremer Hovinga JA, Koch KT, Boekholdt SM, Aken BE
van, Scheepmaker A, Bax M, Schotborgh CE, Piek JJ, Tijssen JGP,
Reitsma PH, Winter RJ de.
Relationship between in vitro lipopolysaccharide-induced cytokine response in
whole blood, angiographic in-stent restenosis, and toll-like receptor 4 gene
_____________________________________________________________________
QCA-CMS-References
36
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
polymorphisms.
Clinical Chemistry 2005;51(3): 516-21.
319. Guédès A, Keller P-F, L'Allier PL, Lespérance J, Grégoire J, Tardif J-C.
Long-term safety of intravascular ultrasound in nontransplant, nonintervened,
atherosclerotic coronary arteries.
JACC 2005; 45 (4): 559-64.
320. Mehilli J, Ndrepepa G, Kastrati A, Nekolla SG, Markwardt C, Bollwein H,
Pache J, Martinoff S, Dirschinger J, Schwaiger M, Schömig A.
Gender and myocardial salvage after reperfusion treatment in acute myocardial
infarction.
JACC 2005; 45(6): 828-31.
321. Ge L, Iakovou I, Sangiorgi GM, Chieffo A, Melzi G, Cosgrave J,
Montorfano M, Michev I, Airoldi F, Carlino M, Corvaja N, Colombo A.
Treatment of saphenous vein graft lesions with drug-eluting stents. Immediate
and midterm outcome.
JACC 2005; 45(7): 989-94.
322. Fujii K, Carlier SG, Mintz GS, Yang Y-M, Moussa I, Weisz G, Dangas G,
Mehran R, Lansky AJ, Kreps EM, Collins M, Stone GW, Moses JW, Leon
MB.
Stent underexpansion and residual reference segment stenosis are related to stent
thrombosis after sirolimus-eluting stent implantation. An intravascular
ultrasound study.
JACC 2005; 45(7): 995-8.
323. Ellis SG, Popma JJ, Lasala JM, Koglin JJ, Cox DA, Hermiller J,
O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J,
Stone GW.
Relationship between angiographic late loss and target lesion revascularizaton
after coronary stent implantation. Analysis from the TAXUS-IV Trial.
JACC 2005; 45(8): 1193-200.
324. Tsagalou E, Chieffo A, Iakovou I, Ge L, Sangiorgi GM, Corvaja N, Airoldi
F, Montorfano M, Michev I, Colombo A.
Multiple overlapping drug-eluting stents to treat diffuse desease of the left
anterior descending coronary artery.
JACC 2005; 45(10): 1570-3.
325. Colombo A, Mikhail GW, Michev I, Iakovou I, Airoldi F, Chieffo A,
Rogacka R, Carlino M, Montorfano M, Sangiorgi GM, Corvaja N,
Stankovic G.
Treating chronic total occlusions using subintimal tracking and reentry: the
STAR technique.
Cathet Cardiovasc Intervent 2005;64(4): 407-11.
_____________________________________________________________________
QCA-CMS-References
37
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
326. Iakovou I, Sangiorgi GM, Stankovic G, Corvaja N, Vitrella G, Ferraro M,
Colombo A.
Results and follow-up after implantation of four or more sirolimus-eluting stents
in the same patient.
Cathet Cardiovasc Intervent 2005;64(4): 436-9
327. Fischell TA, Maheshwari A, Mirza RA, Haller S, Carter AJ, Popma JJ.
Impact of frame selection on quantitative coronary angiographic analysis after
coronary stenting.
Cathet Cardiovasc Intervent 2005;64(4): 460-7.
328. Ge L, Iakovou I, Cosgrave J, Chieffo A, Montorfano M, Michev I, Airoldi
F, Carlino M, Melzi G, Sangiorgi GM, Corvaja N, Colombo A.
Immediate and mid-term outcomes of sirolimus-eluting stent implantation for
chronic total occlusions.
Eur Heart J 2004; 26 (11): 1056-62.
329. Mavrogeni SI, Manginas A, Papadakis E, Douskou M, Cokkinos D, Katsiva
V, Foussas S, Voudris V, Giakoumelos A, Seimenis I, Baras P, Cokkinos
DV.
Coronary flow evaluation by TIMI frame count and magnetic resonance flow
velocity in patients with coronary artery ectasia.
J Cardiovasc Magn Reson 2005; 7 (3): 545-550.
330. Pache J, Dibra A, Mehilli J, Dirschinger J, Schömig A, Kastrati A.
Drug-eluting stents compared with thin-strut bare stents for the reduction of
restenosis: a prospective, randomized trial.
Eur Heart J 2005; 26 (13): 1262-8.
331. Hausleiter J, Kastrati A, Wessely R, Dibra A, Mehilli J, Schratzenstaller T,
Graf I, Renke-Gluszko M, Behnisch B, Dirschinger J, Wintermantel E,
Schömig A for the investigators of the Individualizable Drug-Eluting Stent
System to Abrogate Restenosis Project.
Prevention of restenosis by a novel drug-eluting stent system with a doseadjustable, polymer-free, on-site stent coating.
Eur Heart J 2005; 26 (15): 1-475-81.
332. Janssen JP, Koning G, Koning PJH de, Bosch JG, Tuinenburg JC, Reiber
JHC.
A new approach to contour detection in X-Ray arteriograms. The Wavecontour.
Invest Radiol 2005; 40: 514-20.
333. Kobori Y, Tanaka N, Takazawa K, Yamashina A.
Usefulness of fractional flow reserve in determining the indication of target
lesion revascularization.
Cathet Cardiovasc Intervent 2005;65(3): 355-60.
334. Dibra A, Kastrati A, Mehilli J, Pache J, Oepen R. van, Dirschinger J,
Schömig A.
Influence of stent surface topography on the outcomes of patients undergoing
_____________________________________________________________________
QCA-CMS-References
38
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
coronary stenting: a randomized double-blind controlled trial.
Cathet Cardiovasc Intervent 2005;65(3): 374-80.
335. Lefèvre T, Garcia E, Reimers B, Lang I, Mario C di, Colombo A, Neumann
F-J, Chavarri MV, Brunel P, Grube E, Thomas M, Glatt B, Ludwig J, on
behalf of the X AMINE ST Investigators.
X-Sizer for thrombectomy in acute myocardial infarction improves ST-segment
resolution.
Results of the X-sizer in AMI for negligible embolization and optiomal ST
resolution (X AMINE ST) Trial.
JACC 2005; 46(2): 246-52.
336. Kobori Y, Tanaka N, Takazawa K, Yamashina A.
Usefulness of fractional flow reserve in determining the indication of target
lesion revascularization.
Cathet Cardiovasc Intervent 2005;65(3): 355-60.
337. Hanekamp CEE, Bonnier HJRM, Michels RH, Peels KH, Heijmen EPCM,
Hagen E van, Koolen JJ.
Initial results and long-term clinical follow up of an amorphous hydrogenated
silicon-carbide coated stent in daily practice.
Int J Cardiovasc Interv 1998; 1: 81-6.
338. Hanekamp C, Koolen J, Bonnier H, Oldroyd K, Boer M-J de, Heublein B,
Visser C, for the Small Vessel Study Group.
Randomized comparison of balloon angioplasty versus silicon carbon-coated
stent implantation for De Novo Lesions in small coronary arteries.
Am J Cardiol 2004; 93: 1233-7.
339. Commeau P, Barragan PT, Roquebert PO, Siméoni JB.
ISR II Study: A long-term evaluation of sirolimus-eluting stent in the treatment
of patients with in-stent restenotic native coronary artery lesions.
Cathet Cardiovasc Intervent 2005;66(2): 158-62.
340. Buellesfeld L, Gerckens U, Mueller R, Schmidt T, Grube E.
Polymer-based paclitaxel-eluting stent for treatment of chronic total occlusions
of native coronaries: results of a Taxus CTO registry.
Cathet Cardiovasc Intervent 2005;66(2): 173-7.
341. Hanekamp C, Koolen J, Bonnier H, Oldroyd K, Boer M-J, Heublein B,
Visser C for the Small Vessel Study group.
A randomized comparison of balloon angioplasty versus silicon carbon coated
stent implantation for denovo lesions in small coronary arteries.
Am J Cardiol 2004; 93: 1233-7.
342. Weber T, Auer J, O'Rourke MF, Kvas E, Lassnig E, Lamm G, Stark N,
Rammer M, Eber B.
Increased arterial wave reflections predict severe cardiovascular events in
patients undergoing percutaneous coronary interventions.
_____________________________________________________________________
QCA-CMS-References
39
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
Eur Heart J 2005; 26: 2657-63.
343. Zohlnhöfer D, Hausleiter J, Kastrati A, Mehilli J, Goos C, Schühlen H,
Pache J, Pogatsa-Murray G, Heemann U, Dirschinger J, Schömig A.
A randomized, double-blind, placebo-controlled trial on restenosis prevention by
the receptor tyrosine kinase inhibitor imatinib.
JACC 2005; 46(11): 1999-2003.
344. Alfonso F, Pérez-Vizcayno MJ, Gómez-Recio M, Insa L, Calvo I,
Hernández JM, Bullones JA, Hernández R, Escaned J, Macaya C, GamaRibeiro V, Leitao-Marques A, for the Restenosis Intrastent: balloon
angioplasty versus elective stenting (RIBS) investigators.
Implications of the 'Watermelon Seeding' phenomenon during coronary
interventions for in-stent restenosis.
Cathet Cardiovasc Intervent 2005;66(4): 521-7.
345. Chaves AJ, Sousa AGMR, Mattos LA, Abizaid A, Feres F, Staico R,
Centemero M, Tanajura LF, Abizaid AC, Rodrigues A, Paes A, Mintz GS,
Sousa JE.
Pilot study with an intensified oral sirolimus regimen for the prevention of instent restenosis in de novo lesions: a serial intravascular ultrasound study.
Cathet Cardiovasc Intervent 2005;66(4): 535-40.
346. Legrand V, Kelbaek H, Hauptmann KE, Glogar D, Rutsch W, Grollier G,
Vermeersch P, Elias J, De Cock CC for the CLASS Investigators.
Clinical and angiographic analysis with a cobalt alloy coronary stent (driver) in
stable and unstable angina pectoris.
Am J Cardiol 2006; 97: 349-52.
347. Garot P, Lefèvre T, Savage M, Louvard Y, Bamlet WR, Willerson JT,
Morice M-C, Holmes DR.
Nine-month outcome of patients treated by percutaneous coronary interventions
for bifurcation lesions in the recent era.
A report from the prevention of restenosis with tranilast and its outcomes
(PRESTO) trial.
JACC 2005; 46: 606-12.
348. Kelbaek H, Thuesen L, Helqvist S, Kløvgaard L, Jørgensen E, Aljabbari S,
Saunamäki K, Krusell LR, Jensen GVH, Bøtker HE, Lassen JF, Andersen
HR, Thayssen P, Galløe, Weert A van, for the SCANDSTENT
Investigators.
The stenting coronary arteries in non-stress/benestent disease (SCANDSTENT)
Trial.
JACC 2006; 47: 449-55.
349. Mehilli J, Dibra A, Kastrati A, Pache J, Dirschinger J, Schömig A, for the
Intracoronary Drug-Eluting Stenting to Abrogate Restenosis in Small
Arteries (ISAR-SMART 3) study investigators.
Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary
_____________________________________________________________________
QCA-CMS-References
40
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
vessels.
Eur Heart J 2006; 27: 260-6.
350. Costa RA, Mintz GS, Carlier SG, Lansky AJ, Moussa I, Fujii K,
Takebayashi H, Yasuda T, Costa JR, Tsuchiya Y, Jensen LO, Cristea E,
Mehran R, Dangas GD, Iyer S, Collins M, Kreps EM, Colombo A, Stone
GW, Leon MB, Moses JW.
Bifurcation coronary lesions treated with the 'Crush' technique. An intravascular
ultrasound analysis.
JACC 2005; 46: 599-605.
351. Garot P, Lefèvre T, Savage M, Louvard Y, Bamlet WR, Willerson JT,
Morice M-C, Holmes DR.
Nine-month outcome of patients treated by percutaneous coronary interventions
for bifurcation lesions in the recent era. A report from the Prevention of
Restenosis With Tranilast and its Outcomes (PRESTO) Trial.
JACC 2005; 46: 606-12.
352. Ge L, Airoldi F, Iakovou I, Cosgrave J, Michev I, Sangiorgi GM,
Montorfano M, Chieffo A, Carline M, Corvaja N, Colombo A.
Clinical and angiographic outcome after implantation of drug-eluting stents in
bifurcation lesions with the crush stent technique. Importance of final kissing
balloon post-dilation.
JACC 2005; 46: 613-20.
353. Schlüter M, Tübler T, Lansky A, Kähler S, Berger J, Mathey DG, Schofer
J.
Angiographic and clinical outcomes at 8 months of cutting balloon angioplasty
and ß-brachytherapy for native vessel in-stent restenosis (BETACUT): Results
from a stopped randomized controlled trial.
Cathet Cardiovasc Intervent 2005;66(3): 320-6.
354. Lee MS, Shah AP, Aragon J, Jamali A, Dohad S, Kar S, Makkar RR.
Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts.
Cathet Cardiovasc Intervent 2005;66(4): 507-11.
355. Baks T, Geuns R-J van, Duncker DJ, Cademartiri F, Mollet NR, Krestin
GP, Serruys PW, Feyter PJ de.
Prediction of left ventricular function after drug-eluting stent implantation for
chronic total coronary occlusions.
JACC 2005; 47: 721-5.
356. Price MJ, Cristea E, Sawhney N, Kao JA, Moses JW, Leon MB, Costa RA,
Lansky AJ, Teirstein PS.
Serial angiographic follow-up of sirolimus-eluting stents for unprotected left
main coronary artery revascularization.
JACC 2005; 47: 871-7.
357. Ge L, Airoldi F, Iakovou I, Cosgrave J, Michev I, Sangiorgi GM,
Montorfano M, Chieffo A, Carlino M, Corvaja N, Colombo A.
_____________________________________________________________________
QCA-CMS-References
41
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
Clinical and angiographic outcome after implantation of drug-eluting stents in
bifurcation lesions with the crush stent technique. Importance of final kissing
balloon post-dilation.
JACC 2005; 46 (4): 613-20.
358. Lee MS, Shah AP, Dang N, Berman D, Forrester J, Shah PK, Aragon J,
Jamal F, Makkar RR.
Coronary sinus is dilated and outwardly displaced in patients with mitral
regurgitation: quantitative angiographic analysis.
Cathet Cardiovasc Intervent 2006;67(3): 490-4.
359. Carter AJ, Brodeur A, Collingwood R, Ross S, Gibson L, Wang CA, Haller
S, Coleman L, Virmani R.
Experimental efficacy of an everolimus eluting cobalt chromium stent.
Cathet Cardiovasc Intervent 2006;68: 97-103.
360. Alfonso F, Pérez-Vizcayno MJ, Hernandez R, Bethencourt A, Martí V,
López-Mínguez J, Angel J.
A randomized comparison of sirolimus-eluting stent with balloon angioplasty in
patients with in-stent restenosis.
J Am Coll Cardiol 2006;47(11):2152-60.
361. Liistro F, Fineschi M, Angioli P, Sinicropi G, Falsini G, Gori T, Ducci K,
Bravi A, Bolognese L.
Effectiveniss and safety of sirolimus stent implantation for coronary in-stent
restenosis.
J Am Coll Cardiol 2006;48(2):270-5.
362. Granér M, Varpula M, Kahri J, Salonen RM, Nyyssönen K, Nieminen M,
Taskinen M-R, Sylvänne.
Association of carotid intima-media thickness with angiographic severity and
extent of coronary artery disease.
Am J Cardiol 2006;97(5):624-9.
363. Hoye A, Iakovou I, Ge L, Mieghem CA van, Ong A, Cosgrave J, Sangiorgi
G, Airoldi F.
Long-term outcomes after stenting of bifurcation lesions with the crush
technique.
J Am Coll Cardiol 2006;47(10):1949-58.
364. Kawarada O, Yokoi Y, Takemoto K, Morioka N, Nakata S, Shiotani S.
The performance of renal duplex ultrasonography for the detection of
hemodynamically significant renal artery stenosis.
Cathet Cardiovasc Intervent 2006;68:311-18.
365. Cosgrave J, Melzi G, Biondi-Zoccai G, Airoldi F, Chieffo A, Sangiorgi G,
Montorfano M, Michev I.
Drug-eluting stent restenosis – the pattern predicts the outcome.
J Am Coll Cardiol 2006;47(12):2399-404.
_____________________________________________________________________
QCA-CMS-References
42
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
366. Granér M, James R, Kahri J, Nieminen M, Syvänne M, Taskinen MR.
Association of paraoxonase-1 activity and concentration with angiographic
severity and extent of coronary artery disease.
J Am Coll Cardiol 2006;47(12):2429-35.
367. Nasu K, Tsuchikane E, Katoh O, Vince G, Virmani R, Surmely JF, Murata
A, Takeda Y.
Accuracy of in vivo coronary plaque morphology assessment – a validation
study of in vivo virtual histology compared with in vitro histopathology.
J Am Coll Cardiol 2006;47(12):2405-12.
368. Fajadet J, Wijns W, Laarman G-J, Kuck K-H, Ormiston J, Münzel T,
Popma JJ, Fitzgerald PJ, Bonan R, Kuntz RE for the ENDEAVOR II
Investigators.
Randomized, double-blind, multicenter study of the endeavor zotarolimuseluting phosphorylcholine-encapsulated stent for treatment of native coronary
artery lesions. Clinical and angiographic results of the Endeavor II trial.
Circulation 2006;114: 798-806.
369. Hoeven BL van der, Liem S-S, Oemrawsingh PV, Dijkstra J, Jukema JW,
Putter H, Atsma DE, Wall EE van der, Bax JJ, Reiber JHC, Schalij MJ.
Role of calcified spots detected by intravascular ultrasound in patients with STsegment elevation acute myocardial infarction.
Am J Cardiol 2006;98:309-13.
370. Tsuchiya Y, Lansky AJ, Costa RA, Mehran R, Pietras C, Shimada Y,
Sonoda S, Cristea E, Negoita M, Dangas GD, Moses JW, Leon MB,
Fitzgerald PJ, Müller R, Störger H, Hauptmann KE, Grube E.
Effect of everolimus-eluting stents in different vessel sizes (from the Pooled
Future I and II trials).
Am J Cardiol 2006;98:464-9.
371. Dzavik V, Kharbanda R, Ivanov J, Ing DJ, Bui S, Mackie K, Ramsamujh
R, Barolet A, Schwartz L, Seidelin PH.
Predictors of long-term outcome after crush stenting of coronary bifurcation
lesions: importance of the bifurcation angle.
Am Heart J 2006: 152: 762-9.
372. Jonas M, Fang JC, Wang JC, Giri S, Elian D, Har-Zahav Y, Ly H, Seifert
PA, Popma JJ, Rogers C.
In-stent restenosis and remote coronary lesion progression are coupled in cardiac
transplant vasculopathy but not in native coronary artery disease.
J Am Coll Cardiol 2006;48(3):453-61.
373. Kawarada O, Yokoi Y, Takemoto K, Morioka N, Nakata S, Shiotani S.
The performance of renal duplex ultrasonography for the detection of
hemodynamically significant renal artery stenosis.
Cathet Cardiovasc Intervent 2006;68: 311-8.
_____________________________________________________________________
QCA-CMS-References
43
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
374. Turco MA, Buchbinder M, Popma JJ, Weissman NJ, Mann T, Doucet S,
Johnson WL, Greenberg JD, Leadley K, Russel ME.
Pivotal, randomized U.S. study of the Symbiot-tm covered stent system in
patients with saphenous vein graft disease: eight-month angiographic and
clinical results from the symbiot III trial.
Cathet Cardiovasc Intervent 2006; 68: 379-88.
375. Elezi S, Dibra A, Mehilli J, Pache J, Wessely R, Schömig A, Kastrati A.
Vessel size and outcome after coronary drug-eluting stent placement. Results
from a large cohort of patients treated with sirolimus- or paclitaxel-eluting
stents.
J Am Coll Cardiol 2006;48(7): 1304-9.
376. Corbett SJ, Cosgrave J, Melzi G, Babic R, Biondi-Zoccai GGL, Godino C,
Morici N, Airoldi F, Michev I, Montorfano M, Sangiorgi GM, Bonizzoni E,
Colombo A.
Patterns of restenosis after drug-eluting stent implantation: insights from a
contemporary and comparative analysis of sirolimus- and paclitaxel-eluting
stents.
Eur Heart J 2006; 27: 2330-7.
377. Pache J, Dibra A, Schaut C, Schühlen H, Dirschinger J, Mehilli J, Kastrati
A, Schömig A.
Sustained increased risk of adverse cardiac events over 5 years after
implantation of gold-coated coronary stents.
Cathet Cardiovasc Intervent 2006;68: 690-5.
378. Kandzari DE, Leon MB, Popma JJ, Fitzgerald PJ, O’Shaughnessy C, Ball
MW, Turco M, Applegate RJ, Gurbel PA, Midei MG, Badre SS, Mauri L,
Thompson KP, LeNarz LA, Kuntz RE for the Endeavor III investigators.
Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with
native coronary artery disease. A randomized controlled trial.
J Am Coll Cardiol 2006;48(12): 2440-7.
379. Wijpkema JS, Dorgelo J, Willems TP, Tio RA, Jessurun GAJ, Oudkerk M,
Zijlstra F.
Discordance between anatomical and functional coronary stenosis severity. 16slice multidetector CT and fractional flow reserve.
Neth Heart J 2007; 15: 5-11.
380. Moses JW, Nikolsky E, Mehran R, Cambier PA, Bachinsky WB, Leya F,
Kuntz RE, Popma JJ, Schleckser P, Wang H, Cohen SA, Leon MB for the
SIRIUS 2.25 Investigators.
Safety and efficacy of the 2.25-mm sirolimus-eluting Bx velocity stent in the
treatment of patients with de novo native coronary artery lesions: the SIRIUS
2.25 trial.
Am J Cardiol 2006; 98: 1455-60.
_____________________________________________________________________
QCA-CMS-References
44
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
381. Takano M, Ohba T, Inami S, Seimiya K, Sakai S, Mizuno K.
Angioscopic differences in neointimal coverage and in persistence of thrombus
between sirolimus-eluting stents and bare metal stents after a 6-month
implantation.
Eur Heart J 2006; 27: 2189-95.
382. Lim VY, Buellesfeld L, Gerckens U, Mueller R, Schmidt T, Grube E.
Use of Taxus polymer-coated Paclitaxel-eluting stents for treatment of in-stent
restenosis in real world patients: results of clinical and angiographic follow-up at
six months in a single-center registry.
Cathet Cardiovasc Intervent 2006;68: 343-8.
383. Corbett SJ, Cosgrave J, Colombo A.
Concurrent implantation of Sirolimus- and Paclitaxel-eluting stents in the same
vessel.
Cathet Cardiovasc Intervent 2007;69: 109-14.
384. Price MJ, Giap H, Teirstein PS.
Intracoronary radiation therapy for multi-drug resistant in-stent restenosis: Initial
clinical experience.
Cathet Cardiovasc Intervent 2007;69: 132-4.
385. Goktekin O, Kaplan S, Dimopoulos K, Barlis P, Tanigawa J, Vatankulu
MA, Koning G, Tuinenburg JC, Di Mario C.
A new quantitative analysis system for the evaluation of coronary bifurcation
lesions: comparison with current conventional methods.
Cathet Cardiovasc Intervent 2007; 69: 172-180.
386. Adriaenssens T, Mehilli J, Wessely R, Ndrepepa G, Seyfarth M, Wieczorek
A, Blaich B, Iijima R, Pache J, Kastrati A, Schömer A.
Does addition of estradiol improve the efficacy of a rapamycin-eluting stent?
Results of the ISAR-PEACE randomized trial.
JACC 2007;49(12):1265-71
387. Agostoni P, Cosgrave J, Biondi-Zoccai GGL, Sangiorgi GM, Ge L, Merzi G,
Corbett S, Airoldi F, Montorfano M, Chieffo A, Michev I, Carlino M,
Colombo A.
Angiographic analysis of pattern of late luminal loss in sirolimus- and
paclitaxel-eluting stents.
Am J Cardiol 2006; 09.104
_____________________________________________________________________
QCA-CMS-References
45
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
388. Amano T, Matsubara T, Uetani T, Nanki M, Marui N, Kato M, Arai K, Yokoi
K, Ando H, Ishii H, Izawa H, Murohara T.
Impact of metabolic syndrome on tissue characteristics of angiographically mild to
moderate coronary lesions.
JACC 2007;49(11):1149-56
389. Larose E, Ganz P, Reynold G, Dorbala S, Di Carli MF, Brown KA, Kwong
RY.
Right ventricular dysfunction assessed by cardiovascular magnetic resonance
imaging predicts poor prognosis late after myocardial infarction.
JACC 2007;49(8): 855-62
390. Turco MA, Ormiston JA, Popma JJ, Mandinov L, O’Shaughnessy CD, Mann
T, McGarry TF, Wu CJ, Chan C, Webster MWI, Hall JJ, Mishkel GJ,
Cannon LA, Baim DS, Koglin J.
Polymer-based, paclitaxel-eluting TAXUS Liberté stent in de novo lesions. The
pivotal TAXUS ATLAS trial.
JACC 2007;49(16): 1676-83
391. De Mario C, Morici N, Godino C, Goktekin O, Tamburino C, Barbagallo R,
Antoniucci D, Grube E, Airoldi F, Biondi Zoccai G, Colombo A, Santiorgi
GM.
Predictors of restenosis after treatment of bifurcational lesions with paclitaxel
eluting stents: a multicenter prospective registry of 150 consecutive patients.
Cathet Cardiovasc Interv 2007; 69:416-424
392. Lee MS, Jurewitz D, Aragon J, Forrester J, Makkar RR, Kar S.
Stent fracture associated with drug-eluting stents: clinical characteristics and
implications.
Cathet Cardiovasc Interv 2007; 69:387-394
393. Aoki J, Nakazawa G, Tanabe K, Hoye A, Yamamoto H, Nakayama T, Onuma
Y, Higashikuni Y, Otsuki S, Yagishita A, Yachi S, Nakajima H, Hara K.
Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent
implantation.
Cathet Cardiovasc Interv 2007; 69:380-386
394. Tiroch K, Koch W, Beckerath N von, Kastrati A, Schömig.
Heme oxygenase-1 gene promoter polymorphism and restenosis following
coronary stenting.
Eur Heart J 2007; 28:968-973
395. Galassi AR, Colombo A, Buchbinder M, Grasso C, Tomasello SD, Ussia GP,
Tamburino C.
Long-term outcomes of bifurcation lesions after implantation of drug-eluting stents
with the “mini-crush technique”.
Cathet Cardiovasc Interv 2007; 69:976-983
396. Cademartiri F, Schuijf JD, Pugliese F, Mollet NR, Jukema W, Maffei E, Kroft
LJ, Palumbo A, Ardissino D, Serruys PW, Krestin GP, Wal EE van der,
Feyter PJ de, Bax JJ.
Usefulness of 64-slice multislice computed tomography coronary angiography to
assess in-stent restenosis.
JACC 2007;49(22):2204-10
_____________________________________________________________________
QCA-CMS-References
46
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
397. Okura H, Taguchi H, Kubo T, Toda I, Yoshida K, Yoshiyama M, Yoshikawa
J.
Atherosclerotic plaque with ultrasonic attenuation affects coronary reflow and
infarct size in patients with acute coronary syndrome. An intravascular ultrasound
study.
Circulation 2007;71:648-653
398. Cosgrave J, Melzi G, Corbett S, Biondi-Zoccai GGL, Agostoni P, Babic R,
Airoldi F, Chieffo A, Sangiorgi GM, Montorfano M, Michev I, Carlino M,
Colombo A.
Comparable clinical outcomes with paclitaxel- and sirolimus-eluting stents in
unrestricted contemporary practice.
JACC 2007;49(24):2320-8
399. Sankatsing RR, Groot E de, Jukema JW, Feyter PJ de, Pennell DJ,
Schoenhagen P, Nissen SE, Stroes ESG, Kastelein JJP.
Surrogate markers for atherosclerotic disease.
Curr Opin Lipidol 2005;16:434-441
400. Pijls NHJ, Schaardenburgh P van, Manoharan G, Boersma E, Bech JW, Veer
M van ‘t, Bär F, Hoorntje J, Koolen J, Wijns W, Bruyne B de.
Percutaneous coronary intervention of functionally nonsignificant stenosis. 5-Year
follow-up of the DEFER study.
JACC 2007;49(21):2105-11
401. Schuijf JD, Bax JJ, Jukema JW, Lamb HJ, Warda HMA, Vliegen HW, Roos
A de, Wall EE van der.
Feasibility of assessment of coronary stent patency using 16-slice computed
tomography.
Am J Cardiol 2004; 94: 427-430
402. Erglis A, Narbute I, Kumsars I, Jegere S, Mintale I, Zakke I, Strazdins U,
Saltups A.
A randomized comparison of paclitaxel-eluting stents versus bare-metal stents for
treatment of unprotected left main coronary artery stenosis.
JACC 2007;50 (6):491-7
403. Schömig K, Ndrepepa G, Mehilli J, Pache J, Kastrati A, Schömig A.
Thoracic radiotherapy in patients with lymphoma and restenosis after coronary
stent placement.
Cathet Cardiovasc Interv 2007; 70:359-365
404. Escolar E, Mintz GS, Popma J, Michalek A, Kim SW, Mandinov L, Koglin J,
Stone G, Ellis SG, Grube E, Dawkins KD, Weissman NJ.
Meta-analysis of angiographic versus intravascular ultrasound parameters of drugeluting stent efficacy (from TAXUS IV, V and VI).
Am J Cardiol 2007; 100:621-626
405. Moses JW, Weisz G, Mishkel G, Caputo R, O’Shaughnessey C, Wong SC,
Fischell TA, Mooney M, Williams DO, Popma JJ, Fitzgerald P, Smith S,
Kuntz RE, Collins M, Cohen SA, Leon MB.
The SIRIUS-DIRECT trial: a multi-center study of direct stenting using the
sirolimus-eluting stent in patients with de novo native coronary artery lesions.
Cathet Cardiovasc Interv 2007; 70:505-512
_____________________________________________________________________
QCA-CMS-References
47
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
406. Mauri L, Cox D, Hermiller J, Massaro J, Wahr J, Tay SW, Jonas M, Popma
JJ, Pavliska J, Wahr D, Rogers C.
The PROXIMAL trial: proximal protection during saphenous vein graft
intervention using the proxis embolic protection system. A randomized,
prospective, multicenter clinical trial.
JACC 2007;50(15):1442-9
407. Wessely R, Kastrati A, Mehilli J, Dibra A, Pache J, Schömig A.
Randomized trial of rapamycin- and paclitaxel-eluting stents with identical
biodegradable polymeric coating and design.
Eur Heart J 2007;28:2720-2725
408. Gershlick A, Kandzari DE, Leon MB, Wijns W, Meredith IT, Fajadet J,
Popma JJ, Fitzgerald PJ, Kuntz RE.
Zotarolimus-eluting stents in patients with native coronary artery disease: clinical
and angiographic outcomes in 1,317 patients.
Am J Cardiol 2007;100:45M-55M
409. Chamuleau SAJ, Eck-Smit BLF, Meuwissen M, Koch KT, Dijkgraaf MGW
Verberne HJ, Tijssen JGP, Piek JJ.
Long-term prognostic value of CFVR and FFR versus perfusion scintigraphy in
patients with multivessel disease.
Neth Heart J 2007;15(11):369-374
410. Abizaid A, Popma JJ, Tanajura LF, Hattori K, Solberg B, Larracas C, Feres
F, Ribamar Costa J de, Schwartz LB.
Clinical and angiographic results of percutaneous coronarh revascularization using
a trilayer stainless steel-tantalum-stainless steel phosphorycholine-coated stent: the
TriMaxx trial.
Cathet Cardiovasc Interv 2007; 70:914-919
411. Braun P.
Prospective randomized study of the restenotic process in small coronary arteries
using a carbofilm coated stent in comparison with plain old balloon angioplasty: a
multicenter study.
Cathet Cardiovasc Interv 2007; 70:920-927
412. Frøbert O, Veer M van’t, Aarnoudse W, Simonsen U, Koolen JJ, Pijls NHJ.
Acute myocardial infarction and underlying stenosis severity.
Cathet Cardiovasc Interv 2007; 70:958-965
413. Hausleiter J, Meyer T, Hadamitzky M, Zankl M, Gerein P, Dörrler K,
Kastrati A, Martinoff S, Schömig A.
Non-invasive coronary computed tomographic angiography for patients with
suspected coronary artery disease: the coronary angiography by computed
tomography with the use of a submillimeter resolution (CACTUS) trial.
Eur Heart J 2007; 28:3034-3041
414. Tomai F, Reimers B, Luca L de, Galassi AR, Gaspardone A, Ghini AS,
Ferrero V, Favero L, Gioffrè G, Prati F, Tamburino C, Ribichini F.
Head-to-head comparison of sirolimus- and paclitaxel-eluting stent in the same
diabetic patient with multiple coronary artery lesions.
Diabetes Care 2008; 31(1):15-19
_____________________________________________________________________
QCA-CMS-References
48
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
415. Hoeven BL van der, Liem SS, Jukema JW, Suraphakdee N, Putter H,
Dijkstra J, Atsma DE, Bootsma M, Zeppenfeld K, Oemrawsingh PV, Wall EE
van der, Schalij MJ.
Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment
elevation myocardial infarction: 9-month angiographic and intravascular
ultrasound results and 12-month clinical outcome.
JACC 2008; 51(6):618-26
416. Suzuki N, Kozuma K, Ueno Y, Nagaoka K, Kyono H, Ishikawa S, Watanabe
H, Yokoyama N, Takeshita S, Isshiki T.
Serial quantitative coronary analysis for the evaluation of one-year change in
saphenous vein grafts.
Ann Thorac Surg 2008; 85:525-9
417. Coolong A, Baim DS, Kuntz RE, O’Malley AJ, Marulkar S, Cutlip DE,
Popma JJ, Mauri L.
Saphenous vein graft stenting and major adverse cardiac events. A predictive
model derived from a pooled analysis of 3958 patients.
Circulation 2008; 117:790-797
418. Meuwissen M, Chamuleau SAJ, Siebes M, Winter RJ de, Koch KT, Dijksman
LM, Berg AJ van den, Tijssen JGP, Spaan JAE, Piek JJ.
The prognostic value of combined intracoronary pressure and blood flow velocity
measurements after deferral of percutaneous coronary intervention.
Cathet Cardiovasc Interv 2008; 71:291-297
419. Courtis J, Rodés-Cabau J, Larose E, Déry JP, Nguyen CM, Proulx G, Gleeton
O, Roy L, Barbeau G, Noël B, DeLarochellière R, Bertrand OF.
Comparison of medical treatment and coronary revascularization in patients with
moderate coronary lesions and borderline fractional flow reserve measurements.
Cathet Cardiovasc Interv 2008; 71:541-548
420. Abizaid A, Chaves AJ, Leon MB, Hauptmann K, Mehran R, Lansky AJ,
Baumbach W, Shankar H, Muller R, Feres F, Sousa AGMR, Sousa JE, Grube
E.
Randomized, double-blind, multicenter study of the polymer-based 17-ß estradioleluting stent for treatment of native coronary artery lesions: six-month results of
the ETHOS I trial.
Cathet Cardiovasc Interv 2007; 70:654-660
421. Muramatsu T, Kozuma K, Tsukahara R, Ito Y, Fujita N, Suwa S, Koyama S,
Saitoh M, Kamiya H, Nakamura M.
Comparison of myocardial perfusion by distal protection before and after primary
stenting for acute myocardial infarction: angiographic and clinical results of a
randomized controlled trial.
Cathet Cardiovasc Interv 2007;70:677-682
422. Baumgart D, Klauss V, Baer F, Hartmann F, Drexler H, Motz W, Klues H,
Hofmann S, Völker W, Pfannebecker T, Stoll HP, Nickenig G.
One-year results of the SCORPIUS study. A German multicenter investigation on
the effectiveness of sirolimus-eluting stents in diabetic patients.
JACC 2007; 50(17):1627-34
_____________________________________________________________________
QCA-CMS-References
49
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
423. Barlis P, Kaplan S, Dimopoulos K, Tanigawa J, Schultz C, Di Mario C.
An indeterminate occlusion duration predicts procedural failure in the
recanalization of coronary chronic total occlusions.
Cathet Cardiovasc Interv 2008; 71:621-628
424. Hoeven BL van der, Pires NMM, Warda HM, Putter H, Quax PHA, Schalij
MJ, Jukema JW.
Dexamethasone-eluting stents for the prevention of in-stent restenosis: evidence
for a differential effect in insulin-dependent and non-insulin-dependent diabetic
patients.
Int J Cardiology 2008; 124:166-171
425. Schuijf JD, Werkhoven JM van, Pundziute G, Jukema JW, Decramer I,
Stokkel MP, Dibbets-Schneider P, Schalij MJ, Reiber JHC, Wall EE van der,
Wijns W, Bax JJ.
Invasive versus noninvasive evaluation of coronary artery disease.
J Am Coll Cardiol Img 2008; 1:190-9
426. Sawada T, Shite J, Garcia-Garcia HM, Shinke T, Watanabe S, Otake H,
Matsumoto D, Tanino Y, Ogasawara D, Kawamori H, Kato H, Miyoshi N,
Yokoyama M, Serruys PW, Hirata K.
Feasibility of combined use of intravascular ultrasound radiofrequency data
analysis and optical coherence tomography for detecting thin-cap fibroatheroma.
Eur Heart J 2008; 29:1136-1146
427. Costa JR, Abizaid A, Feres F, Costa R, Seixas AC, Maia F, Abizaid A,
Tanajura LF, Staico R, Siqueira D, Meredith L, Bhat V, Yan J, Ormiston J,
Sousa AGMR, Fitzgerald P, Sousa JE.
EXCELLATM first-in-man (FIM) study: safety and efficacy of novolimus-eluting
stent in de novo coronary lesions.
Euro Interv 2008; 4:53-58
428. Krucoff MW, Kereiakes DJ, Petersen JL, Mehran R, Hasselblad V, Lansky
AJ, Fitzgerald PJ, Garg J, Turco MA, Simonton CA, Verheye S, Dubois CL,
Gammon R, Batchelor WB, O’Shaughnessy CD, Hermiller JB, Schofer J,
Buchbinder M, Wijns W.
A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single
and multivessel coronary disease.
J Am Coll Cardiol 2008; 51:1543-52
429. Reiber JHC, Zwet PMJ, Koning G, Land CD von, Meurs B van, Gerbrands
JJ, Buis B, Voorthuisen AE van.
Accuracy and precision of quantitative digital coronary arteriography: Observer-,
short-, and medium-term variabilities.
Cath Cardiovasc Diagn 1993; 28:187-198
_____________________________________________________________________
QCA-CMS-References
50
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
430. Steigen TK, Maeng M, Wiseth R, Erglis A, Kumsars I, Narbute I, Gunnes P,
Mannsverk J, Meyerdierks O, Rotevatn S, Niemelä M, Kervinen K, Jensen
JS, Galløe A, Nikus K, Vikman S, Ravkilde J, James S, Aarøe J, Ylitalo A,
Helqvist S, Sjögren I, Thayssen P, Virtanen K, Puhakka M, Airaksinen J,
Lassen JF, Thuesen L.
Randomized study on simple versus complex stenting of coronary artery
bifurcation lesions. The Nordic Bifurcation Study.
Circulation 2006; 114:1955-1961
431. Serruys PW, Luijten HE, Beatt KJ, Geuskens R, Feyter PJ de, Brand M van
den, Reiber JHC, Katen HJ ten, Es GA van, Hugenholtz PG.
Incidence of restenosis after successful coronary angioplasty: a time-related
phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2,
3, and 4 months.
Circulation 1988; 77(2):361-371
432. Anagnostopoulos C, Almonacid A, El Fakhri G, Curillova Z, Sitek A,
Roughton M, Dorbala S, Popma JJ, Di Carli MF.
Quantitative relationship between coronary vasodilator reserve assessed by 82Rb
PET imaging and coronary artery stenosis severity.
Eur J Nucl Med Mol Imaging 2008;35:1593-1601
433. Sjögren P, Fredrikson GN, Samnegard A, Ericsson CG, Öhrvik J, Fisher RM,
Nilsson J, Hamsten A.
High plasma concentrations of autoantibodies against native peptide 210 of apoB100 are related to less coronary atherosclerosis and lower risk of myocardial
infarction.
Eur Heart J 2008;29:2218-2226
434. Beleslin B, Ostojic M, Nedeljkovic M, Stankovic G, Babic R, Stojkovic S,
Saponjski J, Djordjevic-Dikic A, Stepanovic J, Marinkovic J.
Assessment of the reproducibility of the basic parameters obtained from
quantitative coronary arteriography analysis.
Eur Heart J 1995; 16(Abstract Suppl): 296
435. Lespérance J, Bilodeau L, Reiber JHC, Koning G, Hudon G, Bourasse MG.
Issues in the performance of quantitative coronary angiography in clinical research
trials.
What’s new in cardiovascular imaging? Kluwer Academic Publishers, Dordrecht
1998:31-46
436. Koning G, Tuinenburg JC, Hekking E, Peelen J, Weert AWM van, Bergkamp
D, Goedhart B, Reiber JHC.
A novel measurement technique to assess the effects of coronary brachytherapy in
clinical trials.
IEEE Transactions on Medical Imaging 2002; 21(10):1254-1263
_____________________________________________________________________
QCA-CMS-References
51
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
437. Jensen JS, Galløe A, Lassen JF, Erglis A, Kumsars I, Steigen TK, Wiseth R,
Narbute I, Gunnes P, Mannsverk J, Meyerdierks O, Rotevatn S, Niemelä M,
Kervinen K, Nikus K, Vikman S, Ravkilde J, James S, Aarøe J, Ylitalo A,
Helqvist S, Sjögren I, Thayssen P, Virtanen K, Puhakka M, Airaksinen J,
Thuesen L, for the Nordic-Baltic PCI study group.
Safety in simple versus complex stenting of coronary artery bifurcation lesions.
The Nordic bifurcation study 14-month follow-up results.
EuroInterv 2008;4:229-233
438. Tuinenburg JC, Koning G, Seppenwoolde Y, Reiber JHC.
Is there an effect of flat-panel-based imaging systems on quantitative coronary and
vascular angiography?
Cathet Cardiovasc Interv 2006; 68:561-566
439. Oost E, Koning G, Sonka M, Oemrawsingh PV, Reiber JHC, Lelieveldt BPF.
Automated contour detection in x-ray left ventricular angiograms using multiview
active appearance models and dynamic programming.
IEEE Transactions on Medical Imaging 2006; 25(9):1158-1171
440. Chechi T, Vecchio S, Vittori G, Giuliani G, Lilli A, Spaziani G, Consoli L,
Baldereschi G, Biondi-Zoccai GGL, Sheiban I, Margheri M.
ST-segment elevation myocardial infarction due to early and late stent thrombosis.
A new group of high-risk patients.
JACC2008; 51(25)2396-402
441. Uetani T, Amano T, Ando H, Yokoi K, Arai K, Kato M, Marui N, Nanki M,
Matsubara T, Ishii H, Izawa H, Murohara T.
The correlation between lipid volume in the target lesion, measured by intgrated
backscatter intravascular ultrasound, and post-procedural myocardial infarction in
patients with elective stent implantation.
Eur Heart J 2008; 29:1714-1720
442. Chamié D, Abizaid A, Ribamar Costa Júnior J, Feres F, Abizaid A, Staico R,
Costa R, Mattos LAP, Sousa AGMR, Sousa JE.
The revascular active percutaneous interventional device for coronary total
occlusions study.
Cathet Cardovasc Interv 2008;72:156-163
443. Ndrepepa G, Mehilli J, Schulz S, Iijima R, Keta D, Byrne RA, Pache J,
Seyfarth M, Schömig A, Kastrati A.
Prognostic significance of epicardial blood flow before and after percutaneous
coronary intervention in patients with acute coronary syndromes.
JACC 2008;52(7):512-7
444. Ong P, Athanasiadis A, Hill S, Vogelsberg H, Voehringer M, Sechtem U.
Coronary artery spasm as a frequent cause of acute coronary syndrome. The
CASPAR (Coronary artery spasm in patients with acute coronary syndrome) study.
JACC 2008;52(7):523-7
_____________________________________________________________________
QCA-CMS-References
52
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
445. Chan C, Zambahari R, Kaul U, Lau CP, Whitworth H, Cohen S, Buchbinder
M.
A randomized comparison of sirolimus-eluting versus bare metal stents in the
treatment of diabetic patients with native coronary artery lesions: the DECODE
study.
Cath Cardiovasc Interv 2008;72:591-600
446. Acker BAC van, Botma GJ, Zwinderman AH, Kuivenhoven JA, DallingaThie GM, Sijbrands EJG, Boer JMA, Seidell JC, Jukema JW, Kastelein JJP,
Jansen H, Verhoeven AJM.
High HDL cholesterol does not protect against coronary artery disease when
associated with combined cholesteryl ester transfer protein and hepatic lipase gene
variants.
Atherosclerosis 2008;200:161-167
447. Alfonso F, Pérez-Vizcayno MJ, Hernandez R, Fernandez C, Escaned J,
Bañuelos C, Bethencourt A, López-Mínguez JR, Anger J, Cequier A, Sabaté
M, Morís C, Zueco J, Seabra-Gomes R, for the restenosis intra-stent: balloon
angioplasy versus elective stent implantation (RIBS-I) and restenosis intrastent: balloon angioplasty versus elective sirolimus-eluting stenting (RIBS-II)
investigators.
Sirolimus-eluting stents versus bare-metal stents in patients with in-stent
restenosis: results of a pooled analysis of two randomized studies.
Cath Cardiovasc Interv 2008;72:459-467
448. Lansky AJ, Desai KJ, Bonon R, Koning G, Tuinenburg J, Reiber JHC.
Quantitative coronary angiography methodology in vascular brachytherapy II.
Vasc Brachytherapy, Third Edition 2008:543-562
449. Schuijf JD, Werkhoven JM van, Pundziute G, Jukema JW, Decramer I,
Stokkel MP, Dibbets-Schneider P, Schalij MJ, Reiber JHC, Wall EE van
der, Wijns W, Bax JJ.
Invasive versus noninvasive evaluation of coronary artery disease.
J Cardiovasc Imaging 2008; vol 1, no 2: 190-9.
450. Ferenc M, Gick M, Kienzle RP, Bestehorn HP, Werner KD, Comberg T,
Kuebler P, Büttner HJ, Neumann FJ.
Randomized trial on routine vs. provisional T-stenting in the treatment of de novo
coronary bifurcation lesions.
Eur Heart J 2008;29:2859-2867
451. Adriaenssens T, Byrne RA, Dibra A, Iijima R, Mehilli J, Bruskina O,
Schömig A, Kastrati A.
Culotte stenting technique in coronary bifurcation disease: angiographic follow-up
using dedicated quantitative coronary angiographic analysis and 12-month clinical
outcomes.
Eur Heart J 2008;29:2868-2876
_____________________________________________________________________
QCA-CMS-References
53
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
452. Tiroch K, Cannon L, Reisman M, Caputo R, Caulfield T, Heuser R, Braden
G, Low R, Stone G, Almonacid A, Popma JJ.
High-frequency vibration for the recanalization of guidewire refractory chronic
total coronary occlusions.
Cath Cardiovasc Interv 2008;72:771-780
453. Carlino M, Godino C, Latib A, Moses JW, Colombo A.
Subintimal tracking and re-entry technique with contrast guidance: a safer
approach.
Cath Cardiovasc Interv 2008;72:790-796
454. Burzotta F, Parma A, Pristipino C, Manzoli A, Belloni F, Sardella G,
Rigattieri S, Danesi A, Mazzarotto P, Summaria F, Romagnoli E, Prati F,
Trani C, Crea F.
Angiographic and clinical outcome of invasively managed patients with trombosed
coronary bare metal or drug-eluting stents: the OPTIMIST study.
Eur Heart J 2008;29:3011-3021
455. Tamburino C, Angiolillo DJ, Capranzano P, Di Salvo M, Ussia G, Manna A
La, Guzman LA, Galassi AR, Bass TA.
Long-term clinical outcomes after drug-eluting stent implantation in unprotected
left main coronary artery disease.
Cath Cardiovasc Interv 2009;73:291-298
456. Reiber JHC, Tuinenburg JC, Koning G, Janssen JP, Rareş A, Lansky AJ,
Goedhart B.
Chapter 2.2: Quantitative Coronary Arteriography.
Coronary Radiology 2nd Revised Edition,Oudkerk M, Reiser M.F. (eds),Series: Medical
Radiology, Sub series: Diagnostic Imaging, Baert A.L, Knauth M, Sartor K (eds).
Springer-Verlag, Berlin-Heidelberg 2009; p 41-65
457. Burzotta F, Trani C, Todaro D, Mazzari MA, Porto I, Vita M De, Brugaletta
S, Coroleu SF, Niccoli G, Leone AM, Giammarinaro M, Mongiardo R,
Schiavoni G, Crea F.
Outcome of patients trested by a novel thin – strut cobalt- chromium stent in the
drug-eluting stent era: results of the SKYCE (skylor in real world practice) registry.
Cath Cardiovasc Interv 2009;73:457-465
458. Lasava LI, Costa JR, Costa R, Abizaid A, Feres F, Staico R, Maldonado G,
Mattos LA, Beraldo P, Sousa AGMR, Sousa JE, Abizaid A.
Correlation between quantitativ angiographic and intravascular ultrasound
parameters in patients treated with sirolimus analogous-eluting stents.
Int J Cardiovasc Imaging 2009;25:345-351
459. Popma JJ, Tiroch K, Almonacid A, Cohen S, Kandzari DE, Leon MB.
A qualitative and quantitative angiographic analysis of stent fracture late following
sirolimus-eluting stent implantation.
Am J Cardiol 2009;103(7):923-9
460. Pundziute G, Schuijf JD, Jukema JW, Werkhoven JM van, Nucifora G,
Decramer I, Sarno G, Vanhoenacker PK, Reiber JHC, Wijns W, Bax JJ.
Type 2 Diabetes is associated with more advanced coronary atherosclerosis on
multislice computed tomography and virtual histology intravascular ultrasound.
_____________________________________________________________________
QCA-CMS-References
54
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
J Nucl Cardiol 2009; 16 (3); 376-83.
461. Verheye S, Agostoni P, Dubois CL, Dens J, Ormiston J, Worthley S, Trauthen
B, Hasegawa T, Koo BK, Fitzgerald PJ, Mehran R, Lansky AJ.
9-month clinical, angiographic, and intravascular ultrasound results of a
prospective evaluation of the axxess self-expanding biolimus A9-eluting stent in
coronary bifurcation lesions. The DIVERGE (drug-eluting stent intervention for
treating side branches effectively) study.
JACC 2009;53(12):1031-9
462. Fokkema ML, Vlaar PJ, Svilaas T, Vogelzang M, Amo D, Diercks GFH,
Suurmeijer AJH, Zijlstra F.
Incidence and clinical consequences of distal embolization on the coronary
angiogram after percutaneous coronary intervention for ST-elevation myocardial
infarction.
Eur Heart J 2009;30:908-15
463. Byrne RA, Mehilli J, Iijima R, Schulz S, Pache J, Seyfarth M, Schömig A,
Kastrati A for the intracoronary stenting and angiographic results: test
efficacy of 3 limus-eluting stents (ISAR-TEST-2).
A polymer-free dual drug-eluting stent in patients with coronary artery disease: a
randomized trial vs. polymer-based drug-eluting stents.
Eur Heart J 2009;30:923-31
464. Mehilli J, Kastrati A, Byrne RA, Bruskina O, Iijima R, Schulz S, Pache J,
Seyfarth M, Maβberg S, Laugwitz KL, Dirschinger J, Schömig A for the
ISAR-LEFT-MAIN.
Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery
disease.
JACC 2009;53(19):1760-8
465. Hatrick RI, Ormiston JA, Ruygrok PN, Stewart JT, Webber B, Gonzales H,
Webster MWI.
Very late changes in the dilated lesion following coronary balloon angioplasty: a
17 year serial quantitative angiographic study.
EuroInterv 2009;5:121-126
466. Alfonso F, Pérez-Vizcayno MJ, Ruiz M, Suárez A, Cazares M, Hernández R,
Escaned J, Bañuelos C, Jiménez-Quevedo P, Macaya C.
Coronary aneurysms after drug-eluting stent implantation Clinical, angiographic,
and intravascular ultrasound findings.
JACC 2009;53(22):2053-60
467. Suzuki N, Angiolillo DJ, Tannenbaum MA, Driesman MH, Smith C, Bikkina
M, Meckel CR, Morales CE, Xenopoulos NP, Coletta JE, Bezerra HG, Bass
TA, Costa MA.
Strategies for drug-eluting stent treatment of bifurcation coronary artery disease in
the United States: insights from the e-cypher S.T.L.L.R.trial.
Cath and Cardiovasc Interv 2009;73:890-897
_____________________________________________________________________
QCA-CMS-References
55
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
468. Lansky A, Tuinenburg J, Costa M, Maeng M, Koning G, Popma J, Cristea E,
Gavit L, Costa R, Rares A, Es GA van, Lefevre T, Reiber H, Louvard Y,
Morice MC.
Quantitative angiographic methods for bifurcation lesions: a consensus statement
from the European Bifurcation Group.
Cath and Cardiovasc Interv 2009;73:258-266
469. Gouya H, Varenne O, Trinquart L, Touzé E, Vignaux O, Spaulding C, Mas
JL, Sablayrolles JL.
Coronary artery stenosis in high-risk patients: 64-section CT and coronary
angiography – prospective study and analysis of discordance.
Radiol 2009;252(2):377-385
470. Rozenman Y, Witzling V, Tamari I, Turkisher V, Kriviski M, Bode C, Henry
P, Teiger E, Cebrian A, Stoll HP, Spaulding C.
Impact of stent length on restenosis in patients with acute myocardial infarction
treated with primary percutaneous coronary intervention: analysis based on data
from the trial to assess the use of the cypher stent in acute myocardial infarction
treated with balloon angioplasty (TYPHOON).
EuroInterv 2009;5:219-223
471. Feres F, Andrade PB, Costa RA, Ribamar Costa Jr J de, Abizaid A, Staico R,
Tanajura LF, Siqueira D, Maia JP, Lasave L, Sousa AGMR, Sousa JE.
Angiographic and intravascular ultrasound findings following implantation of the
endeavor™ zotarolimus-eluting stents in patients from the real-world clinical
practice.
EuroInterv 2009;5:355-362
472. Furuichi S, Sangiorgi GM, Godino C, Airoldi F, Montorfano M, Chieffo A,
Michev I, Carlino M, Colombo A.
Rotational atherectomy followed by drug-eluting stent implantation in calcified
coronary lesions.
EuroInterv 2009;5:370-374
473. Rathore S, Terashima M, Katoh O, Matsuo H, Tanaka N, Kinoshita Y,
Kimura M, Tuschikane E, Nasu K, Ehara M, Asakura K, Asakura Y, Suzuki
T.
Predictors of angiographic restenosis after drug eluting stents in the coronary
arteries: contemporary practice in real world patients.
EuroInterv 2009;5:349-354
474. Yunoki K, Naruko T, Komatsu R, Ehara S, Shirai N, Sugioka K, Nakagawa
M, Kitabayashi C, Ikura Y, Itoh A, Kusano K, Ohe T, Haze K, Becker AE,
Ueda M.
Enhanced expression of haemoglobin scavenger receptor in accumulated
macrophages of culprit lesions in acute coronary syndromes.
Eur Heart J 2009;30:1844-1852
_____________________________________________________________________
QCA-CMS-References
56
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
475. Lüscher TF, Pieper M, Tendera M, Vrolix M, Rutsch W, Branden F van den,
Gil R, Bischoff KO, Haude M, Fischer D, Meinertz T, Münzel T.
A randomized placebo-controlled study on the effect of nifedipine on coronary
endothelial function and plaque formation in patients with coronary artery disease:
the ENCORE II study.
Eur Heart J 2009;30:1590-1597
476. Villa A, Arnold R, Sánchez PL, Gimeno F, Ramos B, Cantero T, Fernández
ME, Sanz R, Gutiérrez O, Mota P, García-Frade J, San Román JA,
Fernández-Avilés F for the TECAM Research Group.
Comparison of neointimal hyperplasia with drug-eluting stents versus bare metal
stents in patients undergoing intracoronary bone-marrow mononuclear cell
transplantation following acute myocardial infarction.
Am J Cardiol 2009;103:1651-1656
477. Atary JZ, Bergheanu SC, Hoeven BL van der, Atsma DE, Bootsma M, Kley F
van der, Zeppenfeld K, Jukema JW, Schalij MJ.
Impact of sirolimus-eluting stent implantation compared to bare-metal stent
implantation for acute myocardial infarction on coronary plaque composition at
nine months follow-up: a virtual histology intravascular ultrasound analysis.
Results from the Leiden Mission! intervention study.
EuroIntervention 2009;5:565-572
478. Godina C, Parodi G, Furuichi S, Latib A, Barbagallo R, Goktekin O, Cera
M, Mueller R, Tamburino C, Grube E, Mario C Di, Reimers B, Chieffo A,
Antoniucci D, Colombo A, Sangiorgi GM.
Long-term follow-up (four years) of unprotected left main coronary artery disease
treated with paclitaxel-eluting stents (from the TRUE Registry).
EuroIntervention 2010;5:906-916
479. Kastrati A, Balducelli M, Sciascio G Di, Moccetti T, Bortone AS, Colombo
A, Waltenberger J, Hehrlein C.
A European multicentre, randomised study of the MAR-Tyⁿ cobalt chromium
tincoated stent in patients with de novo coronary artery lesions: study design and
protocol.
EuroIntervention 2010;5:976-980
480. Beijk MAM, Klomp M, Verouden NJW, Geloven N van, Koch KT,
Henriques JPS, Baan J, Vis MM, Scheunhage E, Piek JJ, Tijssen JGP,
Winter RJ de.
Genous™ endothelial progenitor cell capturing stent vs. the Taxus Liberté stent
in
patients with de novo coronary lesions with a high-risk of coronary restenosis: a
randomized, single-centre, pilot study.
Eur Heart J 2010;31:1055-1064
481. Beijk MAM, Rittersma SZH, Koch KT, Henriques JPS, Baan J, Vis MM,
Hoekstra F, Tijssen JGP, Piek JJ, Kloek JJ, Mol BAJM de, Winter RJ de.
Long-term follow-up after nonurgent percutaneous coronary intervention in
unprotected left main coronary arteries.
_____________________________________________________________________
QCA-CMS-References
57
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
Cath and Cardiovasc Interv 2010;75:1026-1036
482. Mehilli J, Byrne RA, Tiroch K, Pinieck S, Schulz S, Kufner S, Massberg S,
Laugwitz KL, Schömig A, Kastrati A.
Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of
coronary restenosis in sirolimus-eluting stents.
The ISAR-DESIRE 2 (Intracoronary stenting and angiographic results: drug
eluting stents for in-stent restenosis 2) Study.
JACC 2010;55(24):2710-6
483. Byrne RA, Kastrati A, Tiroch K, Schulz S, Pache J, Pinieck S, Massberg S,
Seyfarth M, Laugwitz KL, Birkmeier KA, Schömig A, Mehilli J, for the
ISAR-TEST-2 Investigators.
2-Year clinical and angiographic outcomes from a randomized trial of polymerfree dual drug-eluting stents versus polymer-based cypher and endeavor, drugeluting stents.
JACC 2010;55(23):2536-43
484. Graaf FR de, Schuijf JD, Velzen JE van, Boogers MJ, Kroft LJ, Roos A de,
Reiber JHC, Sieders A, Spanó F, Jukema JW, Schalij MJ, Wall EE van
der,
Bax JJ.
Diagnostic accuracy of 320-row multidetector computed tomography coronary
angiography to noninvasively assess in-stent restenosis.
Invest Radiol 2010;45: 331-340
485. Kyono H, Kozuma K, Muramatsu T, Suwa S, Fujita N, Koyama S, Saito M,
Isshiki T.
Angiographic impact of the GuardWire system on inflated coronary segments
after
six months: does the distal protection balloon of the GuardWire Plus™ lead to
restenosis?
EuroIntervention 2010;6: 257-260
486. Maia F, Costa JR, Abizaid A, Feres F, Costa R, Staico R, Siqueira D,
Esteves
V, Sousa A, Sousa JE.
Preliminary results of the INSPIRE trial with the novel MGuard™ stent system
containing a protection net to prevent distal embolization.
Cath and Cardiovasc Interv 2010;76:86-92
487. Ndrepepa G, Tiroch K, Fusaro M, Keta D, Seyfarth M, Byrne RA, Pache J,
Alger P, Mehilli J, Schömig A, Kastrati A.
5-Year prognostic value of no-reflow phenomenon after percutaneous coronary
intervention in patients with acute myocardial infarction.
JACC 2010;55(21):2383-9
488. Oikawa Y, Yajima J, Costa MA, Matsuno S, Akabane M, Funada R, Inaba
T, Nakagawa Y, Nakamura M, Nagashima K, Kirigaya H, Ogasawara K,
_____________________________________________________________________
QCA-CMS-References
58
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
Sawada H, Aizawa T.
Intravascular ultrasound, angioscopic and histopathological characterisation of
heterogeneous patterns of restenosis after sirolimus-eluting stent implantation:
insights into potential “thromborestenosis” phenomenon.
EuroIntervention 2010;6:380-387
489. Graaf FR de, Schuijf JD, Velzen JE van, Kroft LJ, Roos A de, Reiber JHC,
Boersma E, Schalij MJ, Spanó F, Jukema JW, Wall EE van der, Bax JJ.
Diagnostic accuracy of 320-row multidetector computed tomography coronary
angiography in the non-invasive evaluation of significant coronary artery
disease.
Eur Heart J 2010;31:1908-1915
490. Rubartelli P, Petronio AS, Guiducci V, Sganzerla P, Bolognese L, Galli M,
Sheiban I, Chirillo F, Ramondo A, Bellotti S, for the Gruppo Italiano di
Studio sullo Stent nelle Occlusioni Coronariche (GISSOC II) GISE
investigators
Comparison of sirolimus-eluting and bare metal stent for treatment of patients
with total coronary occlusions: results of the GISSOC II-GISE multicentre
randomized trial.
Eur Heart J 2010;31:2014-2020
491. Boogers MJ, Schuijf JD, Kitslaar PH, Werkhoven JM van, Graaf FR de,
Boersma E, Velzen JE van, Dijkstra J, Adame IM, Kroft LJ, Roos A de,
Schreur JHM, Heijenbrok MW, Jukema JW, Reiber JHC, Bax JJ.
Automated quantification of stenosis severity on 64-slice CT: A comparison
with quantitative coronary angiography.
JACC 2010;3(7):699-709
492. Kato S, Kitagawa K, Ishida N, Ishida M, Nagata M, Ichikawa Y, Katahira
K, Matsumoto Y, Seo K, Ochiai R, Kobayashi Y, Sakuma H.
Assessment of coronary artery disease using magnetic resonance coronary
angiography. A national multicenter trial.
JACC 2010;56(12):983-91
493. Guagliumi G, Sirbu V, Musumeci G, Bezerra HG, Aprile A, Kyono H,
Fiocca L, Matiashvili A, Lortkipanidze N, Vassileva A, Popma JJ, Allocco
DJ, Dawkins KD, Valsecchi O, Costa MA.
Strut Coverage and vessel wall response to a new-generation paclitaxel-eluting
stent with an ultrathin biodegradable abluminal polymer. Optical Coherence
Tomography Drug-Eluting Stent Investigation (OCTDESI).
Circ Cardiovasc Interv 2010;3:367-375
494. Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M,
Dave R, Ansel G, Lansky A, Cristea E, Collins TJ, Goldstein J, Jaff MR,
for the RESILIENT Investigators
_____________________________________________________________________
QCA-CMS-References
59
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
Nitinol stent implantation versus balloon angioplasty for lesions in the
superficial femoral artery and proximal popliteal artery. Twelve-month result
from the RESILIENT randomized trial.
Circ Cardiovasc Interv 2010; 3: 267-276
495. Verheye S, Agostoni P, Dawkins KD, Dens J, Rutsch W, Carrie D, Schofer
J, Lotan C, Dubois CL, Cohen SA, Fitzgerald PJ, Lansky AJ.
The GENESIS (Randomized, multicenter study of the pimecrolimus-eluting and
pimecrolimus/paclitaxel-eluting coronary stent system in patients with de novo
lesions of the native coronary arteries) trial.
J. Am. Coll. Cardiol. Intv. 2009;2(3):205-214
496. Mahmud E, Ormiston JA, Turco MA, Popma JJ, Weissman NJ,
O’Shaughnessy CD, Mann T, Hall JJ, McGarry TF, Cannon LA, Webster
MWI, Mandinov L, Baim DS.
TAXUS Liberté attenuates the risk of restenosis in patients with medically
treated diabetes mellitus. Results from the TAXUS ATLAS Program.
J. Am. Coll. Cardiol. Intv. 2009;2(3):240-252
497. Byrne RA, Iijima R, Mehilli J, Pinieck S, Bruskina O, Schömig A, Kastrati
A.
Durability of antirestenotic efficacy in drug-eluting stents with and without
permanent polymer.
J. Am. Coll. Cardiol. Intv. 2009;2(4):291-299
498. Niemelä M, Kervinen K, Erglis A, Holm NR, Maeng M, Christiansen EH,
Kumsars I, Jegere S, Dombrovskis A, Gunnes P, Stavnes S, Steigen TK,
Trovik T, Eskola M, Vikman S, Romppanen H, Mäkikallio T, Hansen KN,
Thayssen P, Aberge L, Jensen LO, Hervold A, Airaksinen J, Pietilä M,
Frobert O, Kellerth T, Ravkilde J, Aarøe J, Jensen JS, Helqvist S, Sjögren
I, James S, Miettinen H, Lassen JF, Thuesen L, for the Nordic-Baltic PCI
Study Group.
Randomized comparison of final kissing balloon dilatation versus no final
kissing balloon dilatation in patients with coronary bifurcation lesions treated
with main vessel stenting. The Nordic-Baltic Bifurcation Study III.
Circulation. 2011;123:79-86
499. Ong P, Athanasiadis A, Borgulya G, Voehringer M, Sechtem U.
3-Year follow-up of patients with coronary artery spasm as cause of acute coronary
syndrome. The CASPAR (Coronary Artery Spasm in Patients with Acute
Coronary Syndrome) study follow-up.
JACC 2011;57(2):147-52
500. Finet G, Huo Y, Rioufol G, Ohayon J, Guerin P, Kassab GS.
Structure-function relation in the coronary artery tree: from fluid dynamics to
arterial bifurcations.
EuroIntervention Suppl (2010);Vol. 6 (supplement J):J10-J15
_____________________________________________________________________
QCA-CMS-References
60
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
501. Rodriguez AE, Vigo CF, Delacasa A, Mieres J, Fernandez-Pereira C,
Bernardi V, Bettinoti M, Rodriguez-Granillo AM, Rodriguez-Granillo G,
Santaera O, Curotto V, Rubilar B, Tronge J, Palacios IF, Antoniucci D, on
behalf of EUCATAX investigators.
Efficacy and safety of a double-coated paclitaxel-eluting coronary stent: The
EUCATAX trial.
Cath and Cardiovasc Interv 2011;77:335-342
502. Dudek D, Dziewierz A, Rzeszutko L, Legutko J, Dobrowolski W, Rakowski
T, Bartus S, Dragan J, Klecha A, Lansky AJ, Siudak Z, Zmudka K.
Mesh covered stent in ST-segment elevation myocardial infarction.
EuroIntervention 2010;6:582-589
503. Otsuka Y, Ishiwata S, Inada T, Kanno H, Kyo E, Hayashi Y, Fujita H,
Michishita I.
Comparison of haemodialysis patients and non-haemodialysis patients with
respect to clinical characteristics and 3-year clinical outcomes after sirolimuseluting stent implantation: insights from the Japan multicentre post-marketing
surveillance registry.
Eur Heart Journal (2011);32:829-837
504. Bertrand OF, Larose E, Costerousse O, Mongrain R, Rodés-Cabau J, Déry
JP, Nguyen CM, Barbeau G, Gleeton O, Proulx G, Larochellière R de, Noël
B, Roy L.
Effects of aspiration thrombectomy on necrosis size and ejection fraction after
transradial percutaneous coronary intervention in acute ST-elevation myocardial
infarction.
Cath and Cardiovasc Interv 2011;77:475-482
505. Velzen JE van, Schuijf JD, Graaf FR de, Boersma E, Pundziute G, Spanó F,
Boogers MJ, Schalij MJ, Kroft LJ, Roos A de, Jukema JW, Wall EE van
der, Bax JJ.
Diagnostic performance of non-invasive multidetector computed tomography
coronary angiography to detect coronary artery disease using different endpoints:
detection of significant stenosis vs. detection of atherosclerosis.
Eur Heart Journal (2011);32:637-645
506. Koning G, Reiber JHC.
A new approach to determine optimal viewing angle.
Chin J Radiol 2011;45;(2):195-198
507. Torre Hernandez JM de la, Hernandez FH, Alfonso F, Rumoroso JR,
Lopez-Palop R, Sadaba M, Carrillo P, Rondan J, Lozano I, Ruiz Nodar
JM, Baz JA, Fernandez Nofrerias E, Pajin F, Garcia Camarero T,
Gutierrez H, on behalf of the LITRO Study Group (Spanish Working
Group on Interventional Cardiology).
Prospective application of pre-defined intravascular ultrasound criteria for
assessment of intermediate left main coronary artery lesions. Results from the
multicenter LITRO study.
_____________________________________________________________________
QCA-CMS-References
61
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
JACC 2011;58(4):351-358
508. Aoki J, Lansky AJ, Mehran R, Moses J, Bertrand ME, McLaurin BT, Cox
DA, Lincoff AM, Ohman EM, White HD, Parise H, Leon MB, Stone GW.
Early stent thrombosis in patients with acute coronary syndromes treated with
drug-eluting and bare metal stents. The Acute Catheterization and Urgent
Intervention Triage Strategy Trial.
Circulation 2009;119:687-698
509. Alfonso F, Canales E, Dutary J, Cruz A.
Coronary dissection healing patterns: from complete resolution to restenosis,
insights from optical coherence tomography.
EuroIntervention 2011;7:270-273
510. Kufner S, Massberg S, Dommasch M, Byrne RA, Tiroch K, Ranftl S,
Fusaro M, Schömig A, Kastrati A, Mehilli J, for the Intracoronary stenting
and angiographic results: Test efficacy of 3 Limus-eluting stents (ISARTEST-4) Trial investigators.
Angiographic outcomes with biodegradable polymer and permanent polymer
drug-eluting stents.
Cath and Cardiovasc Interv 2011;78:161-166
511. Okkels Jensen L, Maeng M, Thayssen P, Villadsen A, Krusell L, Botker
HE, Pedersen KE, Aaroe J, Christiansen EH, Vesterlund T, Hansen KN,
Ravkilde J, Tilsted HH, Lassen JF, Thuesen L.
Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimuseluting stent implantation in diabetic patients: the diabetes and drug-eluting stent
(DiabeDES III) angiography and intravascular ultrasound trial.
EuroIntervention 2011;7:323-331
512. Kim JS, Wallace-Bradley D, Alviar CL, Conditt G, Milewski K, Afari ME,
Cheng Y, Gallego C, Tellez A, Stone GW, Kaluza GL, Granada JF.
Correlation of angiographic late loss with neointimal proliferation in stents
evaluated by OCT and histology in porcine coronary arteries.
JACC Cardiovascular imaging 2011;4(9): 1002-1010
513. Hoeven van der BL, Liem SS, Jukema JW, Suraphakdee N, Putter H,
Dijkstra J, Atsma DE, Bootsma M, Zeppenfeld K, Oemrawsingh PV, Wall
van der EE, Schalij.
Serolimus-eluting stents versus bare-metal stents in patients with ST-segemt
evaluation myocardial infarction: 9-month angiographic and intravascular
ultrasound results and 12-month clinical outcome. Results from the mission!
Intervention story.
JACC 2008;51(6)618-626
514. Costa JR, Abizaid A, Feres F, Costa R, Staico R, Siqueira D, Centemero M,
Tanajura LF, Sousa A, Sousa JE.
One-year results of the INSPIRE trial with the novel mguard stent: serial
analysis with QCA and IVUS.
_____________________________________________________________________
QCA-CMS-References
62
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
Catheterization and Cardiovascular Interventions 2011;78: 1095–1100
515. Pompa JJ, Tiroch K, Almonacid A, Cohen C, Kandzari DE, Leon MB,
A qualitative and quantitative angiogravic analysis of stent fracture late
following sirolimus-eluting stent implantation.
The American Journal of Cardiology 2008;12:923-929
516. Erglis A, Kumsars I, Niemela M, Kervinen K, Maeng M, Lassen JF,
Gunnes P, Stavnes S, Jensen JS, Galloe A, Narbute I, Sondore D,
Makikallio T, Ylitalo K, Christiansen EH, Ravkilde J, Steigen TK,
Mannsverk J, Thayssen P, Hansen KN, Syvanne N, Helqvist S, Kjell N,
Wiseth Rune, Aaroe J, Puhakka M, Thuessen L,
Randomrized comparison of coronary bifurcation stenting with the crush versus
the cullote technique using serolimus eluting stents.
Circ Cardiovasc Intervent 2009;2:27-34
517. Janssen JP, Rares A, Tuinenburg JC, Koning G, Lansky AJ, Reiber JHC.
New approaches for the assessment of vessel sizes in quantitative
(cardio-) vascular X-Ray analysis.
Int J Cardiac Imaging 2010;26:259-271
518. Janssen JP, Koning G, Koning de PJH, Tuinenburg JC, Reiber JHC.
A novel approach for the detection of pathlines in X-Ray angiograms: the
wavefront propagation algorithm.
Int J Cardiac Imaging 2002;18: 317-324
519. Holm NR, Hojdahl H, Lassen JF, Thuesen L, Maeng M.
Quantitative coronary analysis in the Nordic Bifurcation studies.
Int J Cardiac Imaging 2011;27:175-180
520. Tuinenburg JC, Koning G, Rares A, Janssen JP, Lansky AJ, Reiber JHC.
Dedicated bifurcation analysis: basic principles.
Int J Cardiovasc Imaging 2011;27:167-174
521. Meredith IT, Worthley S, Whitbourn R, Webster M, Fitzgerald PJ,
Ormiston J.
First-in-human experience with the Medtronic Bifurcation Stent System.
EuroIntervention 2011; 7: 662-669
522. Salvatella N, Morice M-C, Darremont O, Tafflet M, Garot P, Leymarie JL,
Chevalier B, Lefèvre T, Louvard Y, Boudou N, Dumonteil N, Carrié D
Unprotected left main stenting with a second-generation drug-eluting stent: oneyear outcomes of the LEMX Pilot study.
EuroIntervention 2011; 7: 689-696
520. Puricel S, Adorjan P, Oberhänsli M, Stauffer J-C, Moschovitis A, Vogel R,
Goy J-J, Müller O, Eeckhout E, Togni P, Wenaweser P, Meier B,
Windecker S, Cook S.
_____________________________________________________________________
QCA-CMS-References
63
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
Clinical outcomes after PCI for acute coronary syndrome in unprotected left
main coronary artery disease: insights from the Swiss Acute Left Main Coronary
Vessel Percutaneous Management (SALVAGE) study.
EuroIntervention 2011;7: 697-704
521. Ko BS, Camaron JD, Meredith IT, Leung M, Antonis PR, Nasis A, Crossett
M, Hope SA, Lehman SJ, Troupis J, DeFrance T, Seneviratne SK.
Computed tomography stress miocardyocardial perfusion imaging in patients
considered for revascularization: a comparison with fractional flow reserve.
Eur Heart Journal 2012;30:66-77
522. Romagnoli E, Godino C, Lelasi A, Gasparini G, Tzifos V, Sciabasi A, Lioy
E, Presbitero P, Colombo A, Sangiorgi G.
Resolute Italian study in all comers: Imidiate and one- year outcomes.
Cath and Cardiovasc Interv 2012;79:567-574
523. Ong P, Athanasiadis A, Borgulya G, Mahrholdt H, Kaski JC, Sechtem U.
High prevalence of a pathological response to acetylcholine testing in patiens
stable angina pectoris and unobstruckted coronary arteries.
The ACOVA study (Abnormal Coronary VAsomotion in patients with stable
angina and unobstructed coronary arteries)
JACC 2012;59(7):655-662
524. Costa RA, Abizaid A, Abizaid AS, Garcia del Blanco B, Berland J, Petrov I,
Brenot P, Guens RJ van, Royer T, Rubino P, Lesiak M, Fajadet J.
Procedural and early clinical outcomes of patiens with de novo coronary
bifurcation lesions treated with novel Nile PAX dedicated bifurcation
polymer-free paclitaxel coated stents: results from the prospective, multicentre,
non-rendomised BIPAX clinical trial.
EuroInterv 2012;7:1301-1309
525. Karanasos A, Ligthart J, Witberg K, Soest van G, Bruining N, Regar E.
Optical coherence tomography: potential clinical applications.
Curr Cardiovasc Imaging Rep 2012; 3 may online;springerlink.com
526. Karanasos A, Tu S, Heide E van der, Reiber JHC, Regar E
Carina shift as a mechanism for side-branch compromise following main vessel
intervention: insights from three-dimensional optical coherence tomography.
Cardiovasc Diagn Ther 2012; 2(2): 173-177
527. Maehara A, Cristea E, Mintz GS, Lansky AJ, Dressler O, Biro S, Templin
B, Virmani R, Bruyne de B, Serruys PW, Stone GW.
Definitions and methodology for the grayscale and radiofrequency intravascular
ultrasound and coronary angiographic analyses.
J Am Coll Cardiol Img 2012;5: S1-S9
_____________________________________________________________________
QCA-CMS-References
64
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
528. Wykrzykowska JJ, Mintz GS, Garcia-Garcia HM, Maehara A, Fahy M, Xu
K, Inguez A, Fajadet J, Lansky A, Templin B, Zhang Z, Bruyne de B,
Weisz G, Serruys PW, Stone GW.
Longitudinal distribution of plaque burden and necrotic core–rich plaques in
nonculprit lesions of patients presenting with acute coronary syndromes.
J Am Coll Cardiol Img 2012;5: S10-S18
529. Marso SP, Mercado N, Maehara A, Weisz G, Mintz GS, McPherson J,
Schiele F, Dudek D, Fahy M, Xu K, Lansky A, Templin B, Zhang Z, Bruyne
de B, Serruys PW, Stone GW.
Plaque composition and clinical outcomes in acute coronary syndrome patients
with metabolic syndrome or diabetes.
J Am Coll Cardiol Img 2012;5: S42-S52
530. Baber U, Stone GW, Weisz G, Moreno P, Dangas G, Maehara A, Mintz GS,
Cristea E, Fahy M, Xu K, Lansky AJ, Wennerblom B, Mathey DG,
Templin B, Zhang Z, Serruys PW, Mehran R.
Coronary plaque composition, morphology, and outcomes in patients with and
without chronic kidney disease presenting with acute coronary syndromes.
J Am Coll Cardiol Img 2012;5: S53-S61
531. Lansky AJ, Ng VG, Maehara A, Weisz G, Lerman A, Mintz GS, Bruyne de
B, Farhat N, Niess G, Jankovic J, Lazar D, Xu K, Fahy M, Serruys PW,
Stone GW.
Gender and the extent of coronary atherosclerosis, plaque composition, and
clinical outcomes in acute coronary syndromes.
J Am Coll Cardiol Img 2012;5: S62-S72
532. McPherson JA, Maehara A, Weisz G, Mintz GS, Cristea E, Mehran R,
Foster M, Verheye S, Rabbani L, Xu K, Fahy M, Templin B, Zhang Z,
Lansky AJ, Bruyne de B, Serruys BW, Stone GW.
Residual plaque burden in patients with acute coronary syndromes after
successful percutaneous coronary intervention.
J Am Coll Cardiol Img 2012;5: S76-S85
533. Brener SJ, Mintz GS, Cristea E, Weisz G, Maehara A, McPherson JA,
Marso SP, Farhat N, Botker HE, Dressler O, Xu K, Templin B, Zhang Z,
Lansky AJ, Bruyne de B, Serruys PW, Stone GW.
Characteristics and clinical significance of angiographically mild lesions in acute
coronary syndromes.
J Am Coll Cardiol Img 2012;5: S86-S94
534. Sanidas EA, Mintz GS, Maehara A, Cristea E, Wennerblom B, Iñiguez A,
Fajadet J, Fahy M, Dressler O, Weisz G,Templin B, Zhang Z, Lansky AJ,
Bruyne de B, Serruys P, Stone GW.
Adverse cardiovascular events arising from atherosclerotic lesions with and
_____________________________________________________________________
QCA-CMS-References
65
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
without angiographic disease progression
J Am Coll Cardiol Img 2012;5: S95-S105
535. Birgelen von C, Basalus MWZ, Tandjung K, Houwelingen van KW, Stoel
MG, Louwerenburg JW, Linssen GCM, Saïd SAM, Kleijne MAWJ, Sen H,
Löwik MM, Palen van der J, Verhorst PMJ, Man de FHAF.
A randomized controlled trial in second-generation zotarolimus-eluting resolute
stents versus everolimus-eluting Xience V Stents in real-world patients: the
TWENTE trial.
JACC 2012;59;(15):1350-1361
536. Meredith IT, Verheye S, Dubois CL, Dens J, Fajadet J, Carrié D, Walsh S,
Oldroyd KG, Varenne O, Jack el S, Moreno R, Joshi AA, Allocco DJ,
Dawkins KD.
Primary endpoint results of the EVOLVE trial: a randomized evaluation of a
novel bioabsorbable polymer-coated, everolimus-eluting coronary stent.
JACC 2012;59;(15)1362-1370
537. Carrié D, Berland J, Verheye S, Hauptmann KE, Vrolix M, Violini R, Dibie
A, Berti S, Maupas E, Antoniucci D, Schofer J.
A multicenter randomized trial comparing amphilimus- with paclitaxel-eluting
stents in de novo native coronary artery lesions
JACC 2012 59;(15):1371-1376
538. Lezo JS de, Medina A, Martin P, Novoa J, Lezo JS de, Pan M, Caballero E,
Melian F, Mazuelos F, Quevedo V
Predictors of ostial side branch damage during provisional stenting of coronary
bifurcation lesions not involving the side branch origin: an Ultrasonographic
study.
EuroIntervention 2012; 7: 1147-1154
539. Sakakura K, Ako J, Wada H, Kubo N, Momomura S.
ACC/AHA classification of coronary lesions reflects redical resource use in
current percutaneous coronary interventions.
Cath and Cardiovasc Interv 2012;80:370-376
540. Latib A, Colombo A, Castriota F, Micari A, Cremonesi A, De Felice F,
Marchese A, Tespili M, Presbitero P, Sgueglia GA, Buffoli F, Tamburino
C, Varbella F, Menozzi A.
A Randomized Multicenter Study Comparing a Paclitaxel Drug-Eluting Balloon
With a Paclitaxel-Eluting Stent in Small Coronary Vessels
The BELLO (Balloon Elution and Late Loss Optimization) Study
JACC 2012 60;(24):2473-2480
541. Chevalier B, Teiger E. Brunel P, Metzger J-P, Pansieri M, Carrie D, Stoll
H-P, Wittebols K, Spaulding C, Fajadet J.
_____________________________________________________________________
QCA-CMS-References
66
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
One-Year Results of the CRISTAL Trial, a Randomized Comparison of Sypher
Sirolimus-Eluting Coronary Stents versus Balloon Angioplasty for Restenosis of
Drug-Eluting Stents.
Journal of interventional Cardiology 25(6):586-595
542. Kumsars I, Narbute I, Thuesen L, Niemela M, Steigen TK, Kervinen K,
Sondore D, Holm NR, Lassen JF, Christiansen EH, Maeng M, Jegere S,
Juhnevica D, Erglis A, for the Nordic-Baltic PCI Study group
Side branch fractional flow reserve measurements after main vessel stenting: a
Nordic-Baltic Bifurcation Study III substudy
EuroIntervention 2012; 7: 1155-1161.
543. Rolandi MC, Nolte F, Hoef TP van de, Remmelink M, Baan J Jr, Piek JJ,
Spaan JAE, Siebes M
Coronary wave intensity during the Valsalva manoeuvre in humans reflects
altered intramural vessel compression responsible for extravascular resistance.
J Physiol 2012; 00.00: 1-13
544. Stella PR, Belkacemi A, Dubois C, Nathoe H, Dens J, Naber C, Adriaenssen
T, Belle E van, Doevendans P, Agostoni P.
A multicenter randomized comparison of drug-eluting ballon plus bare-metal
stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions
treated with a single-stenting technique: six-month angiographic and 12-month
clinical results of the drug-eluting balloon in bifurcation trial.
Cath and Cardiovasc Interv 2102; 80: 1138-1146
545. Mamas MA, Farooq V, Latib A, Sastry S, D’Souza S, Williams P, Wiper A,
Neyses L, El-Omar M, Fraser DG, Fath-Ordoubadi F
Use of the Sideguard (Cappella) stent in bifurcation lesions: a real-world
experience
EuroIntervention 2012; 7: 1170-1180
546. Rogers JH, Goldstein I, Kandzari DE, Köhler TB, Stinis CT, Wagner PJ,
Popma JJ, Jaff MR, Rocha-Singh KJ.
Zotarolimus-Eluting Peripheral Stents for the Treatment of Erectile Dysfunction
in subjects with suboptimal response to Phosphodiesterase-5 inhibitors
JACC 2012 60;(25):2618-2627
547. Øvrehus KA, Munkholm H, Bøttcher M, Bøtker HE, Nørgaard BL
Coronary computed tomographic angiography in patients suspected of coronary
artery disease: Impact of observer experience on diagnostic performance and
interobserver reproducibility.
J Cardiovasc Computed Tomography 2010; 4: 186-194
542. Nallamothu BK, Spertus JA, Lansky AJ, Cohen DJ, Jones PG, Kureshi F,
Dehmer GJ, Drozda JP, Walsh MN, Brush Jr JE, Koenig GC, Waites TF,
Gantt DS, Kichura G, Chazal RA, O’Brien PK, Valentine CM, Rumsfeld
JS, Reiber JHC, Elmore JG, Krumholz RA, Weaver WD, Krumholz HM.
_____________________________________________________________________
QCA-CMS-References
67
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
Comparison of clinical interpretation with visual assessment and quantitative
coronary angiography in patients undergoing percutaneous coronary intervention
in comtemporary practice: The Assessing Angiography (A2) Project.
Circulation 2013; 127: 1793-1800.
543. Sanidas EA, Maehara A, Barkama R, Mintz GS, Singh V, Hidalgo A,
Hakim D, Leon MB, Moses JW, Weisz G.
Enhanced stent imaging improves the diagnosis of stent underexpansion and
optimizes stent deployment
Cath Cardiovasc Interv 2013; 81: 438-445.
544. Guo J, Maehara A, Mintz GS, Ashida K, Pu J, Shang Y, Leon MB, Stone
GW, Moses JW, Ochiai M
A virtual histology intravascular ultrasound analysis of coronary chronic total
occlusions.
Cath Cardiovasc Interv 2013; 81: 464-470.
545. Waki K, Arakaki Y, Mitsudo K
Long-term outcome of transcatheter polytetrafluoroethylene-covered stent
implantation in a giant coronary aneurysm of a child with Kawasaki disease.
Cath Cardiovasc Interv 2013; 81: 713-716.
546. Teeuwen K, Branden BJL van den, Rahel BM, Laarman GJ, Tijssen JGP,
Kelder JC, Slagboom T, Berg JM ten, Suttorp MJ
Late catch-up in lumen diameter at five-year angiography in MACE-free
patients treated with sirolimus-eluting stents in the Primary Stenting of Totally
Occluded Native Coronary Arteries: a randomised comparison of bare metal
stent implantation with sirolimus-eluting stent implantation for the treatment of
total coronary occlusions (PRISON II).
EuroIntervention 2013; 9: 212-219.
547. Caixeta A, Lansky AJ, Mehran R, Brener SJ, Claessen B, Généreux P,
Palmerini T, Witzenbichler B, Guagliumi G, Brodie BR, Dudek D, Fahy M,
Dangas GD, Stone GW.
Predictors of suboptimal TIMI flow after primary angioplasty for acute
myocardial infarction: results from the HORIZONS-AMI trial
EuroIntervention 2013; 9: 220-227.
548. Staico R, Costa MA, Chamié D, Bezerra H, Armanganijan LV, Costa RA,
Costa JR, Siqueira D, Centemero M, Chaves A, Tanajura LF, Abizaid A,
Feres F, Sousa JEMR, Sousa AGMR
Very long-term follow-up of strut apposition and tissue coverage with Biolimus
A9 stents analyzed by optical coherence tomography
Int J Cardiovasc Imaging 2013; 29: 977-988.
549. Optical coherence tomography guided in-stent thrombus removal in
patients with acute coronary syndromes
Giorgio A Di, Capodanno D, Ramazzotti V, Imola F, Mallus MT, Stazi F,
Paoletti G, Biondi-Zoccai G, Tamburino C, Prati F
_____________________________________________________________________
QCA-CMS-References
68
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
Int J Cardiovasc Imaging 2013; 29: 989-996.
550. Graaf MA de, Jukema JW
High coronary plaque burden: a heavy burden
Eur Heart J 2013 doi:10.1093/eurheartj/eht298
551. Moynagh A, Salvatella N, Harb T, Darremont O, Boudou N, Dumonteil N,
Lefevre Th, Carrie D, Louvard Y, Leymarie J-L, Chevalier B, Morice M-C,
Garot P
Two-year outcomes of everlimus vs. paclitaxel-eluting stent for the treatment of
unprotected left main lesions: a propensity score matching comparison of
patients included in the French Left Main Taxus (FLM Taxus) and the LEft
Main Xience (LEMAX) registries.
Eurointervention 2013; 9(4): 452-462.
552. Dani S, Costa RA, Joshi H, Shah J, Pandya R, Virmani R, Sheiban I, Bhatt
S, Abizaid A
First-in-human evaluation of the novel BioMime sirolimus-eluting coronary
stent with bioabsorbable polymer for the treatment of single de novo lesions
located in native coronary vessels – results from the merit-1 trial.
Eurointervention 2013; 9(4): 493-500
553 Buszman PP, Tellez A, Afari M, Cheng Y, Conditt GB, McGregor JC,
Milewski K, Stenoien M, Kaluza GL, Granada JF
Stent healing response following delivery of paclitaxel via durable polymeric
matrix versus iopromide-based balloon coating in the familial
hypercholesterolaemic swine model of coronary injury
Eurointervention 2013; 9(4): 510-516
554. Birgelen C von, Sen H, Lam MK, Danse PW, Jessurun GAJ, Hautvast
RWM, Houwelingen GK van, Schramm A, Tjon Joe Gin RM,
Louwerenburg JW, Man FHAF de, Stoel MG, Löwik MM, Linssen GCM,
Saïd SAM, Nienhuis MB, Verhorst PMJ, Basalus MWZ, Doggen CJM,
Tandjung K.
Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer
patients requiring a percutaneous coronary intervention (DUTCH PEERS): a
randomised, single-blind, multicenter, non-inferiority trial.
The Lancet http://dx.doi.org/10.1016/S0140-6736(13)62037-1
555. Graaf MA de, Jukema JW
High coronary plaque burden: a heavy load
Eur Heart J 2013; 34: 3168-3170
556. Kubo T, Akasaka T, Shite J, Suzuki T, Uemura S, Yu B, Kozuma K,
Kitabata H, Shinke T, Habara M, Saito Y, Hou J, Suzuki N, Zhang S
OCT compared with IVUS in a coronary lesion assessment
J Am Coll Cardiol Img 2013; 6: 1095-1104
_____________________________________________________________________
QCA-CMS-References
69
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
557. Wu X, Maehara A, He Y, Xu K, Oviedo C, Witzenbichler B, Lansky AJ,
Dressler O, Parise H, Stone GW, Mintz GS
Plaque shift and distal embolism in patients with acute myocardial infarction: a
volumetric intravascular ultrasound analysis from the HORIZONS-AMI trial
Cath and Cardiovasc Interventions 2013; 82: 203-209
558. Pyxaras SA, Tu S, Barbato E, Barbati G, Serafino L Di, Vroey F De, Toth
G, Mangiacapra F, Sinagra G, Bruyne B De, Reiber JHC, Wijns W.
Quantitative angiography and optical coherence tomography for the functional
assessment of nonobstructive coronary stenosis: comparison with fractional
flow reserve.
Am Heart J 2013; (in press)
559. Pyxaras SA, Tu S, Barbato E, Wyffels E, Reiber JHC, Wijns W.
Co-registration of fractional flow reserve and optical coherence tomography
with the use of a three-dimensional angiographic roadmap: an opportunity for
optimization of complex percutaneous coronary interventions.
Eurointervention 2013; 9: in press.
560. Costa RA, Feres F, Staico R, Abizaid A, Costa Jr JR, Siqueira D, Tanajura
LF, Damiani LP, Sousa A, Sousa JE, Colombo A.
Vessel remodeling and plaque distribution in side branch of complex coronary
bifurcation lesions: a grayscale intravasacular ultrasound study.
Int J Cardiovasc Imaging 2013; 29: 1657-1666
561. Gill RJ, Bill J, Michalek A, Vassiliev D, Costa RA
Comparative analysis of lumen enlargement mechanisms achieved with the
bifurcation dedicated BiOSS® stent versus classical coronary stent
implantations by means of provisional side branch stenting strategy: an
intravascular ultrasound study.
Int J Cardiovasc Imaging 2013; 29: 1667-1676
562. Feng T, Yundai C, Hongbin L, Lian C, Zhijun S, Jun G, Qinhua J, Tao Z
Evaluation neointimal coverage in patients with coronary artery aneurysm
formation after drug-eluting stent implantation by optical coherence
tomography.
Int J Cardiovasc Imaging 2013; 29: 1677-1683
563. Kubo S, Kadota K, Otsuru S, Hasegawa D, Shigemoto Y, Habara S, Tada
T, Tanaka H, Fuku Y, Katoh H, Goto T, Mitsudo K
Optimal treatment of recurrent restenosis lesions after drug-eluting stent
implantation for in-stent restenosis lesions
Eurointervention 2013; 9: 788-796
564. Byrne RA, Cassese S, Windisch T, King LA, Joner M, Tada T, Mehilli J,
Pache J, Kastrati A
Differential relative efficacy between drug-eluting stents in patients with bare
metal and drug-eluting stent restenosis; evidence in support of drug resistance:
insights from the ISAR-DESIRE and ISAR-DESIRE 2 trials
_____________________________________________________________________
QCA-CMS-References
70
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
Eurointervention 2013; 9: 797-802
565. Branden BJL van den, Teeuwen K, Koolen JJ, Schaaf RJ van der,
Henriques JPS, Tijssen JGP, Kelder JC, Vermeersch PHMJ, Rensing
BJWM, Suttorp MJ
Primary stenting of Totally Occluded Native Coronary Arteries III (PRISON
III): a randomized comparison of sirolimus-eluting stent implantation with
zotarolimus-eluting stent implantation for the treatment of total coronary
occlusions
Eurointervention 2013; 9: 841-853
566. Bourantas CV, Garcia-Garcia HM, Farooq V, Maehara A, Genereux P,
Diletti R, Muramatsu T, Fahy M, Weisz G, Stone GW, Serruys PW
Clinical and angiographic characteristics of patients likely to have vulnerable
plaques.
JACC: Cardiovasc Imaging 2013; 6(12): 1263-1272
567. Rossi A, Dharampal A, Wragg A, Davies LC, Geuns RJ van,
Anagnostopoulos C, Klotz E, Kitslaar P, Broersen A, Mathur A, Nieman K,
Hunink MGM, Feyter PJ de, Petersen SE, Pugliese F.
Diagnostic performance of hyperaemic myocardial blood flow index obtained
by dynamic computed tomography: does it predict functionally significant
coronary lesions?
Eur Heart J – Cardiovasc Imaging 2014: doi:10.1093/ehjci/jet133
568. Tu S, Holm NR, Janssen JP, Reiber JHC
The fusion of three-dimensional quantitative coronary angiography and
intracoronary imaging for coronary interventions.
In: Computer Vision in Medical Imaging. Ed. CH Chen. World Scientific 2014,
151-173. ISBN 978-981-4460-93-4.
569. Miller CA, Sarma J, Naish JH, Yonan N, Williams SG, Shaw SM, Clark D,
Pearce K. Stout M, Potluri R, Borg A, Coutts G, Chowdhary S, McCann
GP, Parker GJM, Ray SG, Schmitt M.
Multiparametric cardiovascular magnetic resonance assessment of cardiac
allograft vasculopathy.
J Am Coll Cardiol 2014; 63: 799-808.
570. Rolandi MC, Silva K De, Lumley M, Lockie TPE, Clapp B, Spaan JAE,
Perera D, Siebes M
Wave speed in human coronary arteries is not influenced by microvascular
vasodilation: implications for wave intensity analysis
Basic Res Cardiol 2014; 109: 405
571. Nolte F, Hoef TP van de, Meewissen M, Voskuil M, Chamuleau SAJ,
Henriques JPS, Verberne HJ, Eck-Smit BLF van, Koch KT, Winter RJ de,
Spaan JAE, Tijssen JGP, Siebes M, Piek JJ.
_____________________________________________________________________
QCA-CMS-References
71
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
Increased hyperaemic coronary microvascular resistance adds to the presence of
myocardial ischaemia
EuroIntervention 2014;
572. Yonezawa M, Nagata M, Kitagawa K, Kato S, Yoon Y, Nakajima H,
Nakamori S, Sakuma H, Hatakenaka M, Honda H
Quantitative analysis of 1.5-T whole-heart coronary MR angiograms obtained
with 32-channel cardiac coils: a comparison with conventional Quantitative
Coronary Angiography.
Radiology 2014; 271(2): 356-364
573. Xu B, Gao R, Wang J, Yang Y, Chen S, Liu B, Chan F, Li Z, Han Y, Fy G,
Zhao Y, Ge J, for the PEPCAD China ISR Trial Investigators
A prospective, multicenter, randomized trial of Paclitaxel-coated balloon versus
Paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis.
J Am Coll Cardiol Interv 2014; 7: 204-211.
574. Wong DTL, Ko BS, Cameron JD, Leong DP, Leung MCH, Malaiapan Y,
Nerlekar N, Crossett M, Troupis J, Meredith IT, Seneviratne SK
Comparison of diagnostic accuracy of combined assessment using adenosine
stress computed tomography perfusion + computed tomography angiography
with transluminal attenuation gradient + computed tomography angiography
against invasive fractional flow reserve.
J Am Coll Cardiol 2014; 63: 1904-12
575. Carrick D, Oldroyd KG, McEntegart M, Haig C, Petrie MC, Eteiba H,
Hood S, Owens C, Watkins S, Layland J, Lindsay M, Peat E, Rae A, Behan
M, Sood A, Hillis WS, Mordi I, Mahrous A, Ahmed N, Wilson R, Lasalle L,
Genereux P, Ford I, Berry C.
A randomized trial of deferred stenting versus immediate stenting to prevent noor slow reflow in acute ST-segment elevation myocardial infarction (DEFERSTEMI).
J Am Coll Cardiol 2014; 63: 2088-98.
576. Hoef TP van de, Lavieren MA van, Damman P, Delewi R, Piek MA,
Chamuleau SAJ, Voskuil M, Henriques JPS, Koch KT, Winter RJ de,
Spaan JAE, Siebes M, Tijssen JGP, Meeuwissen M, Piek JJ
Physiological basis and long-term clinical outcome of discordance between
fractional flow reserve and coronary flow velocity reserve in coronary stenoses
of intermediate severity.
Circ Cardiovasc Interv 2014 (on-line available)
577. Saito S, Valdes-Chavarri M, Richardt G, Moreno R, Iniguez Romo A,
Barbato E, Carrie D, Ando K, Merkely B, Kornowski R, Eltchaninoff H,
James S, Wijns W, on behalf of the CENTURY II Investigators
_____________________________________________________________________
QCA-CMS-References
72
MEDIS Medical Imaging Systems
_____________________________________________________________________________________________________
A randomized, prospective, intercontinental evaluation of a bioresorbable
polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical
Evaluation of New Temumo Drug-Eluting Coronary Stent System in the
Treatment of Patients with Coronary Artery Disease) trial.
Eur Heart J 2014; 35: 20121-2031.
578. Hishikari K, Yonetsu T, Lee T, Koura K, Murai T, Iwai T, Takagi T, Isobe
M, Iesaka Y, Kakuta T.
Intracoronary electrocardiogram ST-segment elevation in patients with non-STsegment elevation myoacardial infarction and its association with culprit lesion
location and myocardial injury.
EuroIntervention 2014; 10: 105-112.
579. Tada T, Kastrati A, Byrne RA, Schuster T, Cuni R, King LA, Cassese S,
Joner M, Pache J, Massberg S, Schömig A, Mehilli J.
Randomized comparison of biolimus-eluting stents with biodegradable polymer
versus everolimus-eluting stents with permanent polymer coatings assesses by
optical coherence tomography.
Int J Cardiovasc Imaging 2014; 30: 495-504.
_____________________________________________________________________
QCA-CMS-References
73

Angioplastica primaria in un caso di infarto

JT BR E-ventus BX 2014-03-V01 IT low

Angiografia ed Interventistica Cerebrale

2014SAL-390 agg stent nileremedyadvantacre8angiosculpt _dr

Nome MASSIMO UGUCCIONI Telefono 06 5870 4419 Fax 06 5870

angioplastica e stenting delle arterie polmonari

Per esaminare le coronarie basterà una Tac

Download - in slidetube.org

TOC (PDF) - Circulation

dr. reggiani

elenco CIG - Azienda Ospedaliera S.Camillo